Tramadol

RX_TRAMADOL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N02AX02\|N02AJ1[3-6] 1 out of 7 registries used, show all original rules.	49548
4. Check minimum number of events Min. number of events 3	49548
5. Include endpoints None	49548
6. Filter based on genotype QC (FinnGen only)	49548

Control definitions (FinnGen only)

Control exclude: RX_OPIOIDS

Extra metadata

First used in FinnGen datafreeze: DF10

NAME	RX_TRAMADOL
CONTROL_EXCLUDE	RX_OPIOIDS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N02AX02\|N02AJ1[3-6]
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Tramadol based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	49548	26262	23286
Unadjusted period prevalence (%)	9.57	8.95	10.27
Median age at first event (years)	52.36	50.48	54.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
39988: Matched controls
274937

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

6.5

323.0

24040

51926

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

323.0

7036

27398

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

9.5

323.0

1331

993

JN4BD

NOMESCO Finland

Extensive body CT

2.7

323.0

3940

10661

WX320

NOMESCO Finland

Spinalanesthesy

2.7

323.0

9241

27223

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.2

323.0

2899

6592

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

10.2

323.0

2609

1866

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

323.0

5731

14376

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

323.0

20683

105046

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

323.0

18891

62619

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

323.0

3911

10268

WX402

NOMESCO Finland

General anaesthesia

2.2

323.0

6448

21815

AA1AD

NOMESCO Finland

CT of head and brain

2.5

323.0

9159

29193

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.1

323.0

8959

33048

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.4

323.0

4188

12827

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

9.3

323.0

2360

1849

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.5

323.0

4995

10800

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.5

323.0

2607

5346

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

5.5

323.0

2794

3694

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.5

323.0

4497

13041

ZXA00

NOMESCO Finland

Right side

2.9

323.0

11669

34709

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.5

323.0

2600

5396

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

7.9

323.0

6521

6582

L28

ICPC

Limited function/disability (L)

3.7

323.0

6470

13640

L15

ICPC

Knee symptom/complaint

2.7

323.0

8136

23791

L13

ICPC

Hip symptom/complaint

3.1

323.0

5965

14840

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.0

323.0

13111

38065

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

11.2

323.0

3263

2172

205

Kela drug reimbursment

Chronic hypertension

1.9

323.0

9370

38186

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

323.0

6064

21557

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.0

323.0

6952

17748

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

9.0

323.0

1145

899

A28

ICPC

Limited function/disability NOS

2.9

323.0

4878

12580

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.0

323.0

1922

3415

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

323.0

25927

144298

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

5.0

323.0

2279

3284

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

4.7

323.0

3144

4923

S18

ICPC

Laceration/cut

2.6

323.0

17313

62906

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

5.1

323.0

5658

8663

L12

ICPC

Hand/finger symptom/complaint

2.2

323.0

4897

16414

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.4

323.0

2115

4450

TQW40

NOMESCO Finland

Remowal of suture of skin

2.9

323.0

2753

6728

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.2

323.0

7466

26165

L03

ICPC

Low back symptom/complaint

3.4

323.0

11164

28178

L16

ICPC

Ankle symptom/complaint

2.5

323.0

3473

10107

R02

ICPC

Shortness of breath/dyspnoea

2.8

323.0

4547

11958

L90

ICPC

Osteoarthrosis of knee

3.7

323.0

2144

4178

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.6

323.0

2907

4590

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

323.0

9907

38050

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

6.1

323.0

4717

5929

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

17.4

323.0

1332

542

T90

ICPC

Diabetes non-insulin dependent

2.1

323.0

8186

29776

ACC51

NOMESCO Finland

Release of median nerve

3.1

323.0

2864

6692

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.7

323.0

3306

8958

L02

ICPC

Back symptom/complaint

3.0

323.0

3546

8659

L17

ICPC

Foot/toe symptom/complaint

2.4

323.0

9682

32273

L08

ICPC

Shoulder symptom/complaint

2.7

323.0

7697

22285

ZXA10

NOMESCO Finland

Bilateral

2.0

323.0

6341

23183

L86

ICPC

Back syndrome with radiating pain

6.5

323.0

3085

3485

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

6.8

323.0

3269

3552

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.1

323.0

11220

43586

ZX120

NOMESCO Finland

Intravenous

2.8

323.0

3676

9591

R4120

NOMESCO Finland

Occupational therapy

3.1

323.0

2527

5897

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.4

323.0

2758

5855

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

6.4

323.0

1724

1920

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.2

323.0

4511

10459

UJF32

NOMESCO Finland

Coloscopy

2.5

323.0

10353

34268

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

4.8

323.0

2706

4113

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.9

323.0

1108

1327

WX408

NOMESCO Finland

General anesthesy, balanced

3.1

323.0

12800

35825

NF1AA

NOMESCO Finland

Hip X-ray examination

4.9

323.0

3698

5560

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.7

323.0

3300

6497

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.0

323.0

1035

1203

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.4

323.0

4469

13823

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

31.5

323.0

609

135

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

323.0

10745

45415

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.9

323.0

2639

6521

SPAT1229

SPAT

Assessment of need for aid

3.6

323.0

2950

5990

XKD00

NOMESCO Finland

Uroflowmetry

2.0

323.0

5596

20243

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

14.6

323.0

2115

1045

WX111

NOMESCO Finland

Local infiltration anesthesia

5.9

323.0

1207

1438

ZXA05

NOMESCO Finland

Left side

2.8

323.0

10708

32231

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

7.0

323.0

1114

1116

UKC02

NOMESCO Finland

Cystoscopy

2.3

323.0

5975

19597

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.8

323.0

2990

7700

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.5

323.0

1823

3720

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

323.0

6831

19321

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

8.8

323.0

1508

1212

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

7.4

323.0

1102

1046

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

8.4

323.0

5975

5618

R4110

NOMESCO Finland

Physiotherapy

3.1

323.0

12360

34404

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

323.0

4580

15612

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

323.0

2986

7069

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

323.0

4860

15490

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.2

323.0

16198

64499

SPAT1255

SPAT

Intravenous administration of medicine

2.9

323.0

2376

5873

R5140

NOMESCO Finland

Monitoring the use of the aid

2.3

323.0

3818

12238

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

11.9

323.0

1411

841

WX290

NOMESCO Finland

Other blockade of nerve

1.6

323.0

15955

80621

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

323.0

5778

14198

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

323.0

2435

4892

WZC30

NOMESCO Finland

Teaching

2.2

323.0

4641

15633

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

323.0

6262

16157

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.1

323.0

7379

26289

WX002

NOMESCO Finland

Sedation and analgesia

3.0

323.0

8509

22626

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

323.0

18804

100349

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.9

323.0

12178

50791

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.0

323.0

1573

2774

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

323.0

17921

88741

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

323.0

13889

69652

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.7

323.0

11832

36796

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.2

323.0

3839

8885

EBA00

NOMESCO Finland

Extraction of tooth

1.7

323.0

11582

52578

TKC20

NOMESCO Finland

Catheterisation of bladder

2.9

323.0

2663

6680

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

323.0

8901

25724

NE1AA

NOMESCO Finland

Pelvis X-ray examination

5.6

323.0

2877

3770

S97

ICPC

Chronic ulcer skin

4.2

323.0

2113

3575

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

3.9

323.0

2166

3967

WX110

NOMESCO Finland

Local anesthesy

2.1

323.0

26904

136906

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.5

323.0

2944

6124

WZA90

NOMESCO Finland

Other doctors statement

2.0

323.0

8349

32430

WX892

NOMESCO Finland

Monitored bed care

3.0

323.0

2939

7136

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

323.0

13545

66431

SPAT1254

SPAT

Administration of medicine

2.6

323.0

5106

14894

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

323.0

7028

28126

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

323.0

2960

8309

L01

ICPC

Neck symptom/complaint

2.4

323.0

5025

15570

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.6

323.0

3548

7222

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

9.6

323.0

1167

860

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.4

323.0

1286

1676

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

4.4

323.0

2778

4545

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.2

323.0

6920

16671

SPAT1216

SPAT

Assessment of functional ability

2.5

323.0

5183

15458

SPAT1263

SPAT

Sampling

1.7

323.0

14911

70973

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

323.0

9018

36908

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.8

323.0

1901

3542

A01

ICPC

Pain general/multiple sites

4.4

323.0

3487

5903

R05

ICPC

Cough

1.8

323.0

7306

30667

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.2

323.0

8576

29742

E66.01

ICD-10 Finland

Obesity due to excess calories

3.3

323.0

3439

7698

X59

ICD-10 Finland

Exposure to unspecified factor

3.2

323.0

8536

21638

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

3.4

323.0

2284

4848

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

8.3

323.0

3972

3600

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

4.4

323.0

5893

10326

R53

ICD-10 Finland

Malaise and fatigue

2.1

323.0

7269

26225

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

323.0

8294

29353

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.9

323.0

3690

9173

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

323.0

4450

14435

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.9

323.0

5155

13357

M17.1

ICD-10 Finland

Other primary gonarthrosis

3.9

323.0

9342

20030

M54.8

ICD-10 Finland

Other dorsalgia

3.8

323.0

1603

2981

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.0

323.0

2776

6704

C07AB02

ATC

metoprolol; systemic

1.9

323.0

6847

26988

X58

ICD-10 Finland

Exposure to other specified factors

2.8

323.0

5844

15807

S22.3

ICD-10 Finland

Fracture of rib

3.4

323.0

2626

5643

R06.0

ICD-10 Finland

Dyspnoea

2.8

323.0

10294

30177

R42

ICD-10 Finland

Dizziness and giddiness

2.0

323.0

7234

27582

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

323.0

6510

20719

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

4.0

323.0

1816

3251

W19

ICD-10 Finland

Unspecified fall

2.6

323.0

3345

9390

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

8.0

323.0

10580

11826

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

323.0

7940

30547

M70.6

ICD-10 Finland

Trochanteric bursitis

3.5

323.0

4791

10174

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

323.0

11033

35326

M79.6

ICD-10 Finland

Pain in limb

3.2

323.0

16492

49029

SPAT1301

SPAT

No procedures

1.8

323.0

10651

47022

SPAT1310

SPAT

Counselling related to known health issue

1.7

323.0

10705

49582

SPAT1262

SPAT

Handing over of treatment supplies

2.1

323.0

6385

23266

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.7

323.0

15802

52857

R60.0

ICD-10 Finland

Localized oedema

2.9

323.0

4074

10302

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.6

323.0

8750

26842

G44.2

ICD-10 Finland

Tension-type headache

2.6

323.0

5227

15027

R11

ICD-10 Finland

Nausea and vomiting

2.9

323.0

2828

7084

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

323.0

4441

14487

C10AA01

ATC

simvastatin; oral

1.9

323.0

14594

64205

R03BA02

ATC

budesonide; inhalant

2.0

323.0

6391

23502

M43.1

ICD-10 Finland

Spondylolisthesis

6.2

323.0

1925

2222

M48.0

ICD-10 Finland

Spinal stenosis

8.1

323.0

7251

7284

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.5

323.0

3631

10522

R50.9

ICD-10 Finland

Fever, unspecified

2.4

323.0

5364

16378

M54.3

ICD-10 Finland

Sciatica

6.1

323.0

3351

4081

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

323.0

3474

6391

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

323.0

3600

9399

SPAT1153

SPAT

Removal of sutures

2.1

323.0

12021

46238

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.7

323.0

2121

4081

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

323.0

4030

9756

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.7

323.0

4519

12543

M54.1

ICD-10 Finland

Radiculopathy

6.7

323.0

2184

2354

F51.0

ICD-10 Finland

Nonorganic insomnia

2.3

323.0

4896

15809

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.6

323.0

3241

9047

N05CF02

ATC

zolpidem; oral

2.9

323.0

8127

21922

M03BX02

ATC

tizanidine; oral

3.4

323.0

28364

114955

B01AA03

ATC

warfarin; systemic

2.2

323.0

6595

23000

R03DC03

ATC

montelukast; oral

2.2

323.0

5922

20282

P01BA02

ATC

hydroxychloroquine; oral

2.5

323.0

2969

8412

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.5

323.0

12234

41279

A02BC02

ATC

pantoprazole; systemic

3.7

323.0

29005

114063

G04CA02

ATC

tamsulosin; oral

2.0

323.0

8285

31319

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

323.0

7287

26546

M03BC01

ATC

orphenadrine (citrate); systemic

3.6

323.0

12369

30466

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.9

323.0

9431

38907

R52.0

ICD-10 Finland

Acute pain

4.5

323.0

1327

2101

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.0

323.0

5682

14434

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

4.5

323.0

1342

2126

R52.1

ICD-10 Finland

Chronic intractable pain

33.5

323.0

653

136

C08CA01

ATC

amlodipine; oral

2.1

323.0

12539

49913

M54

ICD-10 Finland

Dorsalgia

3.0

323.0

4720

11689

C10AA05

ATC

atorvastatin; oral

1.8

323.0

12971

56788

M01AE01

ATC

ibuprofen; systemic, rectal

2.5

323.0

35450

207939

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.5

323.0

3020

6316

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.4

323.0

5397

16647

J45.1

ICD-10 Finland

Nonallergic asthma

2.8

323.0

2500

6415

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.1

323.0

5084

9532

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

323.0

6341

22942

B01AC04

ATC

clopidogrel; oral

2.2

323.0

5137

17008

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

6.6

323.0

5015

5804

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.1

323.0

3009

6994

M16.1

ICD-10 Finland

Other primary coxarthrosis

4.2

323.0

4738

8488

D07AC01

ATC

betamethasone; topical

1.7

323.0

12096

56009

M09AX01

ATC

hyaluronic acid; parenteral

4.1

323.0

1837

3201

N06AX21

ATC

duloxetine; oral

6.5

323.0

6967

8613

H02BX01

ATC

methylprednisolone, combinations; systemic

3.5

323.0

1964

4050

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

323.0

8846

38096

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

323.0

14988

75562

A46

ICD-10 Finland

Erysipelas

2.6

323.0

5432

15522

R52.9

ICD-10 Finland

Pain, unspecified

3.2

323.0

3485

7878

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.4

323.0

3393

7364

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

3.3

323.0

4152

9338

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.4

323.0

3527

10724

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.0

323.0

5133

18651

A10AE04

ATC

insulin glargine; parenteral

2.4

323.0

3417

10182

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

323.0

13386

63551

R01AD09

ATC

mometasone; nasal

1.6

323.0

16162

80661

N05CF01

ATC

zopiclone; oral

3.4

323.0

15664

43559

N05AH04

ATC

quetiapine; oral

3.1

323.0

7714

19868

N06AA09

ATC

amitriptyline; systemic

7.3

323.0

6663

7338

N06AB03

ATC

fluoxetine; oral

2.6

323.0

5293

15142

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

323.0

7133

27024

J01FA10

ATC

azithromycin; systemic

1.7

323.0

21237

110987

N03AF01

ATC

carbamazepine; oral, rectal

3.5

323.0

2297

4719

M01AH03

ATC

valdecoxib; oral

3.3

323.0

2777

5991

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

323.0

3744

10928

M01AX05

ATC

glucosamine; oral

2.8

323.0

7229

20175

P01AB01

ATC

metronidazole; oral, rectal

2.1

323.0

15749

65494

M02AA07

ATC

piroxicam; topical

2.3

323.0

14570

55344

M01AX01

ATC

nabumetone; oral

4.4

323.0

1992

3232

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.6

323.0

1704

2157

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

9.1

323.0

1670

1304

N06AX03

ATC

mianserin; oral

3.7

323.0

2148

4140

N05BA12

ATC

alprazolam; oral

2.7

323.0

4315

11688

N03AX09

ATC

lamotrigine; oral

4.1

323.0

2312

4041

C09AA05

ATC

ramipril; oral

1.8

323.0

7967

33112

A02BC03

ATC

lansoprazole; oral

2.8

323.0

13041

40995

N02AA05

ATC

oxycodone; systemic

16.3

323.0

8582

4535

B01AF01

ATC

rivaroxaban; oral

2.8

323.0

3945

10485

H02AB07

ATC

prednisone; oral

2.8

323.0

6101

16782

C01DA14

ATC

isosorbide mononitrate; oral

2.3

323.0

4945

15876

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.5

323.0

5430

16491

H02AB06

ATC

prednisolone; systemic

2.9

323.0

20734

74765

J01MA02

ATC

ciprofloxacin; systemic

2.3

323.0

16076

61490

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.2

323.0

1764

2027

A02BA02

ATC

ranitidine; systemic

2.6

323.0

8280

25018

N06AA12

ATC

doxepin; systemic

3.9

323.0

2439

4466

M01AE02

ATC

naproxen; oral, rectal

2.6

323.0

24165

102139

M01AG02

ATC

tolfenamic acid; oral, rectal

1.9

323.0

5554

21050

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

6.6

323.0

1309

1409

E66.8

ICD-10 Finland

Other obesity

4.3

323.0

2580

4344

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.3

323.0

11086

28625

R03BA01

ATC

beclometasone; inhalant

2.1

323.0

5133

18081

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

8.8

323.0

788

629

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

323.0

3144

9120

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.8

323.0

1737

2601

J45.9

ICD-10 Finland

Asthma, unspecified

2.8

323.0

7428

20934

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.0

323.0

2228

5265

Z71.8

ICD-10 Finland

Other specified counselling

1.9

323.0

8372

34378

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.9

323.0

1591

2925

N02AJ13

ATC

tramadol and paracetamol; systemic

31.9

323.0

1800

405

E0000UV

ATC

1.6

323.0

13511

65693

N06AB10

ATC

escitalopram; oral

2.1

323.0

7681

27745

M54.2

ICD-10 Finland

Cervicalgia

3.4

323.0

3062

6475

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

33.0

323.0

1901

415

C03CA01

ATC

furosemide; systemic

3.1

323.0

11591

31879

J01FA09

ATC

clarithromycin; systemic

1.8

323.0

11530

51213

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

323.0

3203

8876

A02BA04

ATC

nizatidine; systemic

2.6

323.0

2890

8100

M01AB08

ATC

etodolac; oral

2.8

323.0

2925

7437

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.2

323.0

1454

1995

I10

ICD-10 Finland

Essential (primary) hypertension

2.1

323.0

21101

94972

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

323.0

3447

8617

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

7.0

323.0

1128

1132

K02.1

ICD-10 Finland

Caries of dentine

1.6

323.0

20635

110077

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

323.0

3388

9733

G47.3

ICD-10 Finland

Sleep apnoea

2.3

323.0

8815

29966

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.7

323.0

4440

12062

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.8

323.0

5212

10535

J20

ICD-10 Finland

Acute bronchitis

2.5

323.0

3502

10105

M25.5

ICD-10 Finland

Pain in joint

2.8

323.0

12671

39157

S06.0

ICD-10 Finland

Concussion

2.5

323.0

3761

11055

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

7.8

323.0

1401

1281

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

4.6

323.0

2744

4306

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.1

323.0

5544

13554

M47.9

ICD-10 Finland

Spondylosis, unspecified

7.5

323.0

1684

1610

N02BE01

ATC

paracetamol; systemic, rectal

5.9

323.0

36636

178239

C07AB07

ATC

bisoprolol; oral

2.3

323.0

18122

72468

N05BA01

ATC

diazepam; systemic, rectal

3.9

323.0

7099

14351

R06AE07

ATC

cetirizine; oral

1.8

323.0

16320

75313

A02BC05

ATC

esomeprazole; systemic

2.7

323.0

17694

62941

J01CA04

ATC

amoxicillin; systemic

1.8

323.0

30428

174062

N06AX11

ATC

mirtazapine; oral

3.3

323.0

15447

43640

N02AX02

ATC

tramadol; systemic, rectal

1204.5

323.0

39790

39142

J01DA01

ATC

[U] cefalexin; systemic

2.1

323.0

25500

125466

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

323.0

9610

40903

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

323.0

19722

91743

M19.0

ICD-10 Finland

Primary arthrosis of other joints

4.1

323.0

4221

7778

A04AA01

ATC

ondansetron; systemic, rectal

3.0

323.0

2142

5054

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

323.0

6417

22762

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

4.7

323.0

1418

2149

N07BA03

ATC

varenicline; oral

3.2

323.0

2257

5010

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.2

323.0

8176

28966

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

323.0

9068

30726

M54.4

ICD-10 Finland

Lumbago with sciatica

5.9

323.0

10204

15054

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.6

323.0

11984

38632

R07.3

ICD-10 Finland

Other chest pain

2.7

323.0

3506

9523

M01AE03

ATC

ketoprofen; systemic, rectal

2.8

323.0

17399

58731

C03DA01

ATC

spironolactone; oral

2.6

323.0

3687

10526

N02AJ06

ATC

codeine and paracetamol; systemic

6.1

323.0

18921

35256

M01AC01

ATC

piroxicam; systemic, rectal

2.3

323.0

5020

16476

A02BC01

ATC

omeprazole; systemic

2.6

323.0

11845

37903

M01AC06

ATC

meloxicam; systemic, rectal

2.6

323.0

15851

55189

J01AA02

ATC

doxycycline; systemic

2.4

323.0

31259

165454

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

44.0

323.0

9143

1837

M47.82

ICD-10 Finland

Other spondylosis, cervical region

6.9

323.0

2057

2142

M01AB05

ATC

diclofenac; systemic, rectal

3.1

323.0

29406

129061

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

323.0

9243

31570

R05FA02

ATC

opium derivatives and expectorants; systemic

1.7

323.0

14645

68243

N02AC04

ATC

dextropropoxyphene; oral

10.7

323.0

2214

1493

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.2

323.0

3388

7783

N06AB06

ATC

sertraline; oral

2.4

323.0

4197

12964

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

20.0

323.0

1233

436

B01AB04

ATC

dalteparin; parenteral

3.5

323.0

1829

3758

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.4

323.0

4285

13123

A06AD11

ATC

lactulose; oral

3.8

323.0

6457

13223

M01AH05

ATC

etoricoxib; oral

3.2

323.0

26376

104009

R03AC02

ATC

salbutamol; inhalant

2.2

323.0

21311

92679

A10BA02

ATC

metformin; oral

2.0

323.0

9949

38893

N05BA04

ATC

oxazepam; oral

3.0

323.0

11423

32389

N05CD07

ATC

temazepam; oral

3.7

323.0

6081

12724

J45

ICD-10 Finland

Asthma

2.4

323.0

3487

10343

M03BC51

ATC

orphenadrine, combinations; systemic

2.7

323.0

12757

40642

J01FA06

ATC

roxithromycin; oral

2.0

323.0

16104

69002

M01AB55

ATC

diclofenac, combinations; oral

4.4

323.0

3227

5404

M01AX17

ATC

nimesulide; oral

3.0

323.0

11323

31739

M01AH02

ATC

rofecoxib; oral

3.7

323.0

6202

13111

M79.1

ICD-10 Finland

Myalgia

2.5

323.0

4920

14619

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.1

323.0

4796

16843

H02AB04

ATC

methylprednisolone; systemic

2.6

323.0

6124

17804

M01AB51

ATC

indometacin, combinations; oral, rectal

5.8

323.0

1231

1508

M01AB01

ATC

indometacin; systemic, rectal

3.0

323.0

3186

7613

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

6.1

323.0

2586

3083

N06AA10

ATC

nortriptyline; systemic

9.2

323.0

1332

1023

M54.6

ICD-10 Finland

Pain in thoracic spine

3.1

323.0

2666

6249

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.1

323.0

5378

18711

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.6

323.0

7319

21854

E66.00

ICD-10 Finland

Metabolic syndrome

3.2

323.0

2154

4835

R51.80

ICD-10 Finland

Headache

3.1

323.0

6490

16261

I50.9

ICD-10 Finland

Heart failure, unspecified

2.4

323.0

4121

12599

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

323.0

4419

14898

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.4

323.0

3411

10192

N03AX12

ATC

gabapentin; oral

11.2

323.0

12052

10203

C07AA05

ATC

propranolol; systemic

2.0

323.0

7162

27323

N04BC05

ATC

pramipexole; oral

3.7

323.0

3058

5975

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.4

323.0

8156

26763

N05AA02

ATC

levomepromazine; systemic

3.4

323.0

1928

4061

R03BB04

ATC

tiotropium bromide; inhalant

3.1

323.0

4090

9849

J01MA12

ATC

levofloxacin; systemic

2.9

323.0

8159

22300

M02AA10

ATC

ketoprofen; topical

2.3

323.0

5985

19731

N03AX16

ATC

pregabalin; oral

12.1

323.0

18519

18348

R05FB02

ATC

cough suppressants and expectorants

1.8

323.0

13956

62914

J01DB01

ATC

cefalexin; oral

2.8

323.0

33100

174371

A03FA01

ATC

metoclopramide; systemic, rectal

2.8

323.0

8627

24699

R03BA05

ATC

fluticasone; inhalant

2.0

323.0

6445

24569

M01AH01

ATC

celecoxib; oral (coxibs)

3.8

323.0

9015

19511

R52.2

ICD-10 Finland

Other chronic pain

9.3

323.0

2101

1627

R03AC03

ATC

terbutaline; inhalant

2.0

323.0

5038

18099

A07EC01

ATC

sulfasalazine; oral, rectal

2.6

323.0

3114

8735

M79.7

ICD-10 Finland

Fibromyalgia

6.1

323.0

1646

1908

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.7

323.0

6802

19161

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.5

323.0

3178

9028

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.7

323.0

2312

3561

M54.5

ICD-10 Finland

Low back pain

4.1

323.0

17098

42745

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.3

323.0

5946

19499

M54.9

ICD-10 Finland

Dorsalgia, unspecified

4.5

323.0

5839

10076

N06AB04

ATC

citalopram; systemic

2.5

323.0

9514

30057

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

323.0

11287

50806

M04AA01

ATC

allopurinol; systemic

2.7

323.0

4816

13169

N06AX16

ATC

venlafaxine; oral

3.8

323.0

7304

15343

J02AC01

ATC

fluconazole; systemic

1.6

323.0

14038

68518

J01EA01

ATC

trimethoprim; systemic

1.7

323.0

8106

35032

N03AE01

ATC

clonazepam; systemic

4.7

323.0

3057

4805

J01FF01

ATC

clindamycin; systemic

2.7

323.0

12197

38895

J01MA14

ATC

moxifloxacin; systemic

2.8

323.0

3516

9301

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

4.0

323.0

3239

5949

B01AB05

ATC

enoxaparin; parenteral

3.4

323.0

13805

36811

XF600

NOMESCO Finland

Bloodpressure measurement

2.9

322.2

2310

5778

AN1

Coronary angiography

2.2

321.3

3684

11927

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

5.2

320.8

1124

1513

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

320.1

14322

72675

R05

ICD-10 Finland

Cough

1.8

319.9

6302

25347

SPAT1260

SPAT

Consultation of another employee

1.9

319.4

5870

23045

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.2

318.3

1111

1489

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.7

317.6

2486

6565

NG2AA

NOMESCO Finland

Patella X-ray examination

5.7

317.2

1029

1262

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.7

316.4

1562

2961

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.2

316.3

1381

2343

SPAT1211

SPAT

Application of soft bandage

2.4

315.6

3004

8861

M01AE51

ATC

ibuprofen, combinations; systemic

7.7

315.4

831

760

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

315.0

2621

7176

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

314.4

25141

145157

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

4.7

311.8

1199

1790

R96

ICPC

Asthma

2.5

311.7

2916

8520

L29

ICPC

Musculoskeletal sympt/complt other

2.6

309.6

2540

6895

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.4

308.4

1741

3678

M05BA04

ATC

alendronic acid; oral

2.7

305.7

2343

6104

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

305.4

6442

26465

N07BB01

ATC

disulfiram; oral

3.1

304.6

1915

4379

N06AX12

ATC

bupropion; oral

2.7

304.2

2342

6119

A07AA02

ATC

nystatin; oral

2.9

303.1

2142

5302

L14

ICPC

Leg/thigh symptom/complaint

2.7

302.2

2445

6580

B01AB10

ATC

tinzaparin; parenteral

2.7

301.9

2303

5981

A03CA02

ATC

clidinium and psycholeptics; oral

2.9

300.8

2141

5324

R35

ICD-10 Finland

Polyuria

2.8

299.8

2246

5768

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

4.5

299.6

1202

1875

R01AD08

ATC

fluticasone; nasal

1.6

299.6

9898

46371

C09CA01

ATC

losartan; oral

1.7

299.2

7565

32870

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.2

298.0

1273

2114

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.4

297.5

1669

3506

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.2

297.4

1820

4081

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

297.0

3337

10679

C08CA13

ATC

lercanidipine; oral

2.1

296.7

4018

13981

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

39.4

296.4

426

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

296.2

7670

33551

C09CA06

ATC

candesartan; oral

1.7

295.8

7125

30494

D01

ICPC

Abdominal pain/cramps general

2.2

295.1

3479

11385

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.1

294.7

1848

4215

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

10.9

294.5

637

408

L84

ICPC

Back syndrome without radiat pain

3.5

294.4

1597

3269

M13.9

ICD-10 Finland

Arthritis, unspecified

2.6

294.2

2556

7163

C10AA07

ATC

rosuvastatin; oral

1.7

294.1

7636

33419

K59.09

ICD-10 Finland

Constipation, unspecified

2.9

292.7

1994

4816

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.1

291.6

1850

4255

A04

ICPC

Weakness/tiredness general

2.1

291.4

3958

13782

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.1

291.0

3993

13964

Z50.1

ICD-10 Finland

Other physical therapy

2.9

290.9

1979

4774

M43.0

ICD-10 Finland

Spondylolysis

6.6

290.5

842

888

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

289.1

15198

79459

A03FA02

ATC

cisapride; oral, rectal

2.5

289.0

2659

7688

M10.9

ICD-10 Finland

Gout, unspecified

2.8

289.0

2158

5526

N30.0

ICD-10 Finland

Acute cystitis

2.0

288.8

4158

14829

A06AH03

ATC

naloxegol; oral

83.0

288.6

371

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

288.5

9602

44984

A10BH01

ATC

sitagliptin; oral

2.3

287.7

3088

9663

S29

ICPC

Skin symptom/complaint other

1.9

287.5

5339

20958

Z51.5

ICD-10 Finland

Palliative care

3.6

287.0

1489

2939

B01AX06

ATC

[U] rivaroxaban; oral

6.6

286.9

834

883

N06AX05

ATC

trazodone; oral

4.5

285.1

1143

1781

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.3

285.0

1676

3647

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.6

284.6

2321

6269

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

284.5

7831

34806

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.5

284.5

1524

3087

C09AA02

ATC

enalapril; systemic

1.8

282.9

6305

26293

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

282.9

20347

113539

C03AA03

ATC

hydrochlorothiazide; oral

2.3

282.6

3052

9575

E66.9

ICD-10 Finland

Obesity, unspecified

3.8

282.5

1368

2547

Z02.7

ICD-10 Finland

Issue of medical certificate

2.7

282.5

2178

5688

WX200

NOMESCO Finland

Interscalenous plexus blockade

6.3

281.9

852

952

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.3

280.5

3082

9748

G04BD12

ATC

mirabegron; oral

2.3

279.9

3033

9528

P06

ICPC

Sleep disturbance

2.2

279.4

3399

11270

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

277.9

3193

10313

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

275.9

5403

21575

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.9

275.7

1295

2347

R03AC13

ATC

formoterol; inhalant

3.0

274.3

1842

4402

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

273.3

22411

128037

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.5

273.0

1446

2901

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

272.8

2576

7542

S80.0

ICD-10 Finland

Contusion of knee

2.6

272.7

2260

6157

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

272.5

6067

25261

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

4.2

272.3

1178

1978

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.4

271.8

918

1182

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

270.4

2408

6831

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.1

269.5

3582

12334

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.9

269.3

1843

4459

130

Kela drug reimbursment

Malignant tumour

2.5

269.1

2362

6646

N01

ICPC

Headache

2.2

268.6

3145

10239

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

268.6

4055

14711

NF1DA

NOMESCO Finland

X-ray of hips

5.9

265.7

839

993

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.6

265.4

2157

5808

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

265.2

9112

42870

R33

ICD-10 Finland

Retention of urine

2.4

264.5

2630

7907

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.1

264.0

1676

3851

M50.3

ICD-10 Finland

Other cervical disc degeneration

4.8

263.7

1000

1469

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.7

262.4

2089

5556

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.6

261.7

1345

2632

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

261.2

2890

9157

J46

ICD-10 Finland

Status asthmaticus

4.4

260.7

1074

1719

J01DA06

ATC

[U] cefuroxime; systemic

1.8

260.6

5131

20492

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.6

259.4

860

1082

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.4

258.0

2578

7767

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

256.9

3187

10640

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

256.6

2646

8098

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.9

255.9

808

956

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

254.5

5733

23904

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

8.3

254.1

634

530

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.9

253.2

1179

2118

R60.9

ICD-10 Finland

Oedema, unspecified

3.0

253.2

1629

3775

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

10.4

252.6

559

375

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

251.8

2446

7260

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.2

250.9

2877

9263

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.6

250.1

2133

5899

A01AB09

ATC

miconazole; local oral

2.2

249.9

2880

9295

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

8.3

249.8

625

525

M15

ICD-10 Finland

Polyarthrosis

3.3

249.3

1410

2976

SPAT1202

SPAT

Intra-articular injection

4.1

249.2

1110

1915

D11

ICPC

Diarrhoea

2.0

249.0

3622

12924

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

4.4

247.9

1009

1595

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

247.7

1970

5231

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

247.6

4092

15337

G43.9

ICD-10 Finland

Migraine, unspecified

2.7

247.4

1965

5213

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.0

247.2

3753

13619

NBG10

NOMESCO Finland

Acromioplastia

4.4

247.0

1021

1639

TAB20

NOMESCO Finland

Epidural puncture

11.5

246.5

519

314

K59.0

ICD-10 Finland

Constipation

2.8

246.3

1852

4754

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.6

246.2

2076

5702

R06AX27

ATC

desloratadine; oral

1.6

246.1

8990

42810

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

3.4

246.0

1381

2897

G04BD08

ATC

solifenacin; oral

2.6

245.6

2081

5732

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.7

245.0

1919

5049

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

245.0

2800

8997

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.1

243.9

1541

3526

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

243.5

5445

22618

M03BX01

ATC

baclofen; systemic

5.6

243.2

798

991

R13

ICD-10 Finland

Dysphagia

2.5

242.8

2120

5939

K10.3

ICD-10 Finland

Alveolitis of jaws

2.9

242.5

1647

3959

C10AX09

ATC

ezetimibe; oral

2.0

241.5

3408

12003

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.0

240.8

1604

3805

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.1

240.3

1051

1782

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

239.1

2291

6747

P76

ICPC

Depressive disorder

2.5

239.0

2145

6099

NG4AA

NOMESCO Finland

Lower leg X-ray examination

4.1

238.9

1068

1848

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

21.0

238.9

400

132

XF402

NOMESCO Finland

ECG with work load test

2.0

238.8

3521

12619

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

238.2

1785

4569

P03

ICPC

Feeling depressed

2.2

236.6

2898

9605

G54.0

ICD-10 Finland

Brachial plexus disorders

4.1

236.1

1031

1745

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

4.8

236.1

888

1292

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

236.1

12807

66558

Z00.0

ICD-10 Finland

General medical examination

1.7

235.8

5937

25543

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.9

235.4

1594

3823

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

7.0

235.2

658

659

D06

ICPC

Abdominal pain localized other

2.3

234.7

2599

8223

K30

ICD-10 Finland

Functional dyspepsia

2.0

233.8

3389

12057

UJD02

NOMESCO Finland

Gastroscopy

2.8

233.4

1693

4246

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

4.7

233.3

895

1330

N03AX11

ATC

topiramate; oral

4.1

233.1

1039

1793

R51

ICD-10 Finland

Headache

2.7

232.9

1778

4603

WX212

NOMESCO Finland

Femoral plexus blockade

6.4

232.9

690

750

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

7.3

232.8

630

600

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.1

232.4

1475

3384

E000001

ATC

1.6

232.2

6749

30222

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

232.0

9222

44703

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.4

231.6

2335

7054

R4190

NOMESCO Finland

Nutritional therapy

3.6

231.4

1203

2374

SPAT1104

SPAT

Monitoring of emergency patient

2.4

230.6

2188

6406

N05BA02

ATC

chlordiazepoxide; systemic

4.0

230.2

1055

1867

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.8

230.2

1651

4109

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2485

6722

2.45

323.31

1.6

246.1

298.1

titre

0.38

283

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1940

4629

2.76

323.31

2.4

1.9

0.0

g/l

0.00

1783

4228

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2238

5770

2.56

321.56

2.9

2.4

3.6

g/l

0.73

2138

5491

(3028707) Methadone [Presence] in Urine by Screen method

1523

3166

3.16

321.50

4.6

2.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5542

20574

1.82

317.13

3.8

24.0

18.4

ug/l

0.63

4560

16081

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

40814

237989

1.62

312.01

5.3

4.2

6.1

5.9

mmol/l

237.09

37471

218906

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

44404

265067

1.85

309.34

15.3

8.5

27.7

26.5

u/l

28.34

43345

255344

(3002032) Base excess in Venous blood by calculation

6091

17667

2.39

307.65

5.1

3.4

1.7

1.9

mmol/l

2.49

5050

14456

(3009261) Glucose [Presence] in Urine by Test strip

24489

114014

1.76

307.65

4.5

3.2

0.0

estimate

0.46

4818

19697

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

27542

105095

2.57

307.65

8.9

5.7

1.2

mmol/l

28.61

23780

88000

(3014111) Lactate [Moles/volume] in Serum or Plasma

6725

16062

2.96

307.65

7.9

6.9

1.3

mmol/l

0.20

6469

15478

(3015736) pH of Urine

19638

86406

1.77

307.65

4.1

3.0

5.6

5.7

0.34

(3009508) Creatinine [Moles/volume] in Urine

17152

68241

1.95

307.65

3.7

3.1

7.5

8.0

mmol/l

1.95

14406

57655

(3048689) Calprotectin [Mass/mass] in Stool

7086

27065

1.80

307.65

2.5

2.3

145.4

127.3

ug/g

2.79

5651

21121

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9671

29153

2.41

307.65

3.1

2.3

2.4

g/l

3.13

8954

26912

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10576

37220

2.05

307.65

1.4

1.2

33.9

37.5

iu/ml

0.47

2952

11918

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

22163

88520

2.12

307.65

2.3

1.8

94.9

96.7

pmol/l

6.06

12117

45992

(3002030) Lymphocytes/100 leukocytes in Blood

25807

107983

2.14

307.65

7.9

5.6

27.0

28.6

87.79

24221

100539

(3023520) Reticulocytes [#/volume] in Blood

5363

15554

2.37

307.65

2.6

2.5

72.1

68.4

e9/l

8.89

3938

11737

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2392

5106

3.11

307.65

2.0

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

18052

63086

2.33

307.65

2.5

2.0

211.1

212.1

u/l

0.04

17072

59002

(3001122) Ferritin [Mass/volume] in Serum or Plasma

22407

99328

1.83

307.65

3.6

2.6

136.2

119.4

ug/l

11.05

20708

92509

(4010399)

4543

14928

2.05

307.65

1.5

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

4533

12135

2.54

307.65

2.5

2.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

10344

31842

2.38

307.65

3.1

2.3

12.4

14.4

umol/l

2.73

9617

29487

(3020564) Creatinine [Moles/volume] in Serum or Plasma

44570

263410

2.00

307.65

26.3

12.4

80.8

76.5

umol/l

72.90

44556

263260

(36304419) Bacteria [Presence] in Urine

16447

55779

2.35

307.65

4.0

2.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2336

5751

2.69

307.65

2.4

2.0

0.7

0.9

g/l

1.28

2025

4903

(40758558) Short blood count panel - Blood

14987

54298

2.12

307.65

8.3

6.0

—

(3024928) Oxygen saturation in Venous blood

1737

3826

2.99

307.65

3.9

3.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9088

24741

2.67

307.65

7.6

5.4

1.1

1.0

mmol/l

17.07

8513

23013

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1958

4683

2.76

307.65

2.4

1.9

0.0

g/l

0.01

1785

4232

(3001604) Monocytes [#/volume] in Blood

27313

110364

2.34

307.65

7.5

5.4

0.6

e9/l

70.14

23765

95476

(3003396) Base excess in Arterial blood by calculation

7922

21402

2.65

307.65

8.0

7.1

0.9

1.0

mmol/l

1.51

6445

16628

(3013650) Neutrophils [#/volume] in Blood by Automated count

30417

128609

2.38

307.65

10.8

8.0

4.3

4.0

e9/l

86.07

26814

111802

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

11712

39439

2.20

307.65

4.5

3.2

284.7

630.5

ng/l

14.76

9060

29167

(3023368) Bacteria identified in Blood by Culture

17752

51176

2.93

307.65

5.4

3.6

—

(3013115) Eosinophils [#/volume] in Blood

28019

114912

2.33

307.65

7.7

5.6

0.2

e9/l

15.61

24797

100828

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4069

10985

2.51

307.65

4.1

3.0

1.7

mmol/l

0.24

3027

7973

(3013826) Glucose [Moles/volume] in Serum or Plasma

31353

127857

2.61

307.65

6.5

4.0

6.8

6.7

mmol/l

11.76

30013

117986

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

34582

185007

1.69

307.65

4.5

3.8

14.8

14.7

pmol/l

7.88

31752

169059

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2435

6451

2.50

307.65

2.3

1.9

9.9

10.4

g/l

5.42

2072

5352

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3798

10195

2.51

307.65

10.3

9.5

—

(3021788) Differential panel - Synovial fluid

1744

2847

4.05

307.65

1.6

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

18776

66713

2.31

307.65

3.3

2.3

56.1

59.8

u/l

6.94

17473

61321

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10548

36581

2.09

307.65

3.3

2.6

2.5

2.4

mmol/l

25.46

9121

31774

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4465

11097

2.75

307.65

7.6

7.1

24.9

24.7

mmol/l

2.15

4421

10982

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

40013

223368

1.84

307.65

7.0

5.1

40.8

39.2

mmol/mol

172.64

37422

207261

(3020630) Protein [Mass/volume] in Serum or Plasma

5390

14965

2.48

307.65

2.7

2.2

66.2

66.7

g/l

4.10

4855

13631

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

29074

112071

2.65

307.65

7.7

5.0

10.7

11.6

umol/l

24.81

27740

105845

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6572

17933

2.57

307.65

2.7

2.1

0.2

g/l

1.85

6103

16661

(40768804) Tissue Pathology biopsy report

19464

96031

1.50

307.65

2.3

2.0

—

(3000991) Gas panel - Venous blood

6383

15244

2.95

307.65

9.8

8.1

—

(3002582) Erythrocytes [#/volume] in Urine

18023

63254

2.32

307.65

4.1

2.9

56.8

99.7

e6/l

4.54

14411

47468

(3028026) IgM [Mass/volume] in Serum or Plasma

4030

11724

2.32

307.65

1.9

1.8

1.3

1.4

g/l

1.09

3663

10746

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

21573

92213

1.90

307.65

2.7

2.1

75.9

1061.1

nmol/l

0.50

19471

83341

(3044941) Cell count panel - Synovial fluid

1439

2420

3.91

307.65

1.6

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

4797

11601

2.84

307.65

9.8

9.3

93.7

94.0

2.33

4774

11559

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3136

8553

2.45

307.65

1.4

1.6

12.6

14.8

u/ml

0.34

282

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10245

32588

2.29

307.65

3.6

2.6

3.2

2.7

e6/l

2.58

5612

17498

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

25889

93537

2.66

307.65

8.0

5.1

1.2

mmol/l

17.04

23993

83789

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1859

3607

3.40

307.65

1.4

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

19807

64339

2.65

307.65

3.1

2.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

33031

146998

2.37

307.65

5.9

3.7

1198.4

1330.4

e6/l

0.14

366

2200

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

13772

45809

2.30

307.65

2.0

1.6

1.2

mg/l

0.04

10705

34497

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1374

1891

4.78

307.65

7.0

5.7

11.5

11.4

mg/l

0.34

1267

1750

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11515

50000

1.63

307.65

1.3

1.5

1.8

u/ml

1.49

2885

14127

(3017143) Hepatitis C virus Ab [Presence] in Serum

6814

25591

1.83

307.65

1.8

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

9811

30509

2.34

307.65

2.4

1.9

30.2

29.6

13.51

9560

29574

(3037522) Nuclear Ab [Titer] in Serum

8794

29629

2.11

307.65

1.4

1.3

497.3

556.6

titre

1.95

1720

5971

(3024354) Oxygen [Partial pressure] in Venous blood

4931

14660

2.29

307.65

4.1

2.8

4.8

4.6

kpa

9.97

4738

14212

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18396

74551

1.94

307.65

4.1

2.9

35.1

33.1

u/l

1.25

17428

70660

(3007164) IgA [Mass/volume] in Serum or Plasma

10680

42686

1.78

307.65

1.6

1.4

2.5

2.4

g/l

8.90

6425

26588

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6553

17781

2.58

307.65

8.9

8.0

121.0

122.9

g/l

9.59

6381

17081

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10739

46209

1.63

307.65

1.8

1.6

17189699.3

38778962.2

pmol/l

4.35

8930

38462

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1859

3608

3.40

307.65

1.4

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5017

14265

2.40

307.65

4.6

3.7

101.1

88.9

ng/l

10.45

4369

12281

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

15599

47926

2.60

307.65

2.9

2.0

—

(3006504) Eosinophils/100 leukocytes in Blood

25347

103822

2.18

307.65

7.8

5.5

2.8

2.9

1.75

23790

96553

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4947

15932

2.11

307.65

3.0

2.7

193.6

204.7

ng/l

0.88

4458

14482

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3815

12076

2.12

307.65

7.9

6.8

24.7

24.5

mmol/l

2.38

3586

11194

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6125

17745

2.39

307.65

5.1

3.4

5.9

5.8

kpa

7.64

5926

17265

(3007853) Bacteria identified in Skin by Aerobe culture

8669

22485

2.80

307.65

2.2

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

43869

243055

2.58

307.65

24.3

10.4

23.8

23.1

mg/l

3.64

38807

183671

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2812

6113

3.08

307.65

2.5

2.2

459.5

554.0

ug/l

0.55

2665

5685

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2596

6922

2.49

307.65

2.3

1.9

3.8

g/l

0.10

1980

4774

(3020682) Albumin/Creatinine [Ratio] in Urine

16307

67444

1.83

307.65

4.3

3.9

12.9

7.9

mg/mmol

18.74

10597

42469

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2570

6783

2.52

307.65

2.2

1.9

2.6

2.2

ug/l

0.73

2285

5979

(3000494) Fungus identified in Specimen by Culture

7148

24989

1.98

307.65

1.6

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2601

6934

2.49

307.65

2.3

1.9

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4733

11637

2.79

307.65

9.8

9.1

1.4

2.78

4703

11548

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2165

4784

3.00

307.65

1.3

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

27798

114240

2.31

307.65

7.5

5.4

1.9

e9/l

0.12

24655

100604

(3013707) Erythrocyte sedimentation rate by Westergren method

36567

171123

2.49

307.65

5.5

3.5

13.7

10.9

mm/h

207.19

34406

158029

(3012095) Magnesium [Moles/volume] in Serum or Plasma

11100

30712

2.71

307.65

3.9

2.9

0.8

mmol/l

38.17

10362

28499

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2110

4528

3.09

307.65

1.5

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4715

11605

2.78

307.65

9.9

9.2

0.7

3.35

4688

11529

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2604

6942

2.49

307.65

2.3

1.9

7.5

7.2

g/l

12.35

2052

5034

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10070

34782

2.08

307.65

1.3

1.2

10.7

11.6

u/ml

0.48

3726

14018

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7666

28673

1.85

307.65

2.1

1.7

1.6

1.4

54.25

6604

25663

(3023103) Potassium [Moles/volume] in Serum or Plasma

44471

250496

2.58

307.65

26.5

12.3

4.0

mmol/l

61.82

43797

242698

(3037467) Urinalysis macro (dipstick) panel - Urine

33518

157831

2.16

307.65

5.6

3.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7602

20362

2.66

307.65

2.0

1.6

—

(40761535) Cells panel - Urine sediment

4849

17001

1.93

307.65

4.2

3.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7952

21398

2.66

307.65

8.0

7.2

5.2

5.1

kpa

11.21

7619

20383

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

40811

230926

1.83

307.65

20.8

10.1

81.5

82.7

ml/min/173m2

20.55

35825

187128

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3214

8325

2.59

307.65

1.7

1.6

1.5

g/l

12.56

2777

7071

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

10613

30165

2.61

307.65

2.1

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

8084

25137

2.28

307.65

24.3

21.1

1.4

1.3

inr

0.33

1049

3707

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7159

21855

2.30

307.65

4.0

4.1

238.7

241.7

u/l

0.78

6767

20672

(3022313) Gas panel - Capillary blood

2997

8146

2.45

307.65

4.3

3.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

2072

2516

5.48

307.65

1.8

1.4

—

(3006315) Basophils [#/volume] in Blood

27450

110908

2.35

307.65

7.5

5.4

0.0

e9/l

7.35

23864

95922

(3036481) Cortisol [Moles/volume] in Serum or Plasma

6126

17953

2.36

307.65

2.3

2.1

351.8

383.2

nmol/l

22.95

5626

16535

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2320

5907

2.60

307.65

2.7

2.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

7943

21390

2.66

307.65

8.0

7.2

12.0

12.7

kpa

21.90

7606

20372

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9152

26818

2.47

307.65

3.2

2.4

21.5

23.8

35.76

8026

22842

(40761511) CBC panel - Blood by Automated count

43665

258442

1.81

307.65

20.8

10.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3991

10998

2.45

307.65

1.6

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

15328

50592

2.38

307.65

2.6

2.1

3.1

2.9

mg/l

16.62

13254

42985

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

30952

164861

1.56

307.65

4.3

2.7

61.2

43.1

u/l

134.74

29072

154521

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7591

20265

2.67

307.65

2.0

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

20606

80576

2.11

307.65

4.4

3.0

66.3

61.6

ng/l

0.15

14414

51147

(3030467) Casts [#/volume] in Urine by Automated count

16878

57281

2.37

307.65

4.0

2.8

0.4

e6/l

0.13

13309

41941

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4948

17109

1.96

307.65

3.0

2.4

64.7

68.0

ml/min/173m2

5.74

2043

6482

(3005719) IgG [Mass/volume] in Serum or Plasma

5095

15136

2.30

307.65

2.9

2.5

10.3

10.8

g/l

11.78

4659

13882

(3035350) Ketones [Presence] in Urine by Test strip

24336

112343

1.78

307.65

4.5

3.2

0.0

estimate

0.55

4866

19762

(3044889) 12 lead EKG panel

32818

164027

1.87

307.65

4.5

3.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7936

23158

2.44

307.65

3.7

2.4

8.1

8.2

umol/l

0.18

6865

20086

(3015377) Calcium [Moles/volume] in Serum or Plasma

18340

71200

2.05

307.65

3.8

2.9

2.4

mmol/l

1.15

16086

61947

(3021960) Folate [Moles/volume] in Serum or Plasma

13352

47390

2.12

307.65

1.7

1.5

20.3

nmol/l

0.01

11558

40579

(3009343) pH of Capillary blood

4211

11388

2.51

307.65

4.1

3.1

7.4

2.12

591

1489

(3016502) Oxygen saturation in Arterial blood

7139

19132

2.64

307.65

8.4

7.6

95.5

95.8

2.48

6933

18363

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4231

9494

3.04

307.65

9.7

9.6

24.3

mmol/l

0.19

3968

8823

(3011397) Hemoglobin [Presence] in Urine by Test strip

12994

50557

1.89

307.65

4.3

3.2

—

(3022145) Colonoscopy Study observation

6458

24720

1.78

307.65

1.4

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

13314

42567

2.39

307.65

3.1

2.4

5.8

5.3

e6/l

2.57

11830

36783

(42870588) Differential panel, method unspecified - Blood

20126

72339

2.34

307.65

7.3

5.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1829

3675

3.28

307.65

3.5

2.5

36.1

33.1

umol/l

3.21

1595

3097

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2411

5120

3.13

307.65

1.5

1.4

263.2

283.3

ug/g

3.97

1446

2869

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

16317

55854

2.32

307.65

3.3

2.7

1471.5

1310.3

ng/l

3.03

13860

47133

(3052851) Hemolysis interference index of Serum or Plasma

2589

5496

3.14

307.65

3.6

2.9

—

(40768797) Stomach Pathology biopsy report

8856

28611

2.21

307.65

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

11117

37171

2.19

307.65

1.9

1.7

1181.7

1152.0

nmol/l

2.44

8599

27895

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2610

6978

2.48

307.65

4.6

3.2

24.8

mmol/l

0.44

2433

6404

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2165

5236

2.73

307.65

2.3

1.9

37.4

37.9

g/l

2.83

1885

4440

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

26274

100330

2.48

307.65

4.8

3.5

—

(3021589) Normoblasts [#/volume] in Blood

22526

102115

1.78

307.65

12.7

8.2

0.0

e9/l

1.65

18516

83933

(3012516) Albumin [Mass/volume] in Urine

15706

63683

1.86

307.65

3.6

3.2

389.6

373.6

mg/l

0.16

10492

39565

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

10873

35026

2.28

307.65

3.4

2.5

1.0

1.1

e6/l

1.32

6212

19794

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

40011

223123

1.84

307.65

5.5

4.4

1.9

2.2

mu/l

2.59

37019

205196

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5448

12593

3.00

307.65

1.8

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

38159

176624

2.78

307.65

10.6

6.1

80.5

75.7

u/l

66.23

36524

165477

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7051

18252

2.73

307.65

3.5

2.2

35.9

48.1

u/l

1.96

6049

15633

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4267

11555

2.51

307.65

4.2

3.1

5.2

5.1

kpa

4.89

3944

10633

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3845

8279

3.15

307.65

5.5

3.8

24.0

24.1

mmol/l

0.95

3496

7381

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2521

6444

2.60

307.65

2.3

1.9

3.1

3.0

g/l

5.58

2016

4931

(3012544) pH of Venous blood

6284

18399

2.37

307.65

5.0

3.5

7.4

0.29

(3014576) Chloride [Moles/volume] in Serum or Plasma

8816

24316

2.62

307.65

8.7

6.6

104.2

104.6

mmol/l

13.65

8644

23771

(3019060) Gas panel - Arterial blood

4322

12220

2.40

307.65

4.9

4.7

—

(3042936) Bacteria identified in Isolate by Culture

10767

25652

3.18

307.65

2.6

1.7

—

(3032080) INR in Blood by Coagulation assay

23826

81589

2.71

307.65

9.8

7.6

1.2

inr

1.88

6684

23974

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2648

5568

3.17

307.65

3.3

2.9

0.3

0.4

u/ml

1.87

1470

3075

(3019069) Monocytes/100 leukocytes in Blood

25454

104425

2.18

307.65

8.1

5.8

8.6

8.5

1.02

23986

97691

(3019550) Sodium [Moles/volume] in Serum or Plasma

44429

249545

2.60

307.65

26.2

12.2

139.4

139.8

mmol/l

193.37

43812

242243

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2109

5087

2.74

307.65

2.3

1.9

0.0

g/l

0.06

1933

4619

(3000475) Leukocytes [#/volume] in Synovial fluid

2145

3810

3.74

307.65

1.7

1.6

16178.8

11358.9

e6/l

3.16

1476

2835

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5564

16288

2.35

307.65

2.6

2.1

6.8

7.9

ug/l

2.88

4795

14281

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6278

20026

2.16

307.65

4.2

2.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

24229

112874

1.75

307.65

5.9

4.3

0.0

estimate

1.45

5012

20300

(3027945) Reticulocytes/100 erythrocytes in Blood

7170

21292

2.36

307.65

2.5

2.4

1.9

1.7

24.39

6326

18819

(3018010) Neutrophils/100 leukocytes in Blood

25484

106419

2.13

307.65

7.6

5.4

58.0

56.9

44.75

23994

99496

(3026493) Urate [Moles/volume] in Serum or Plasma

15727

56276

2.17

307.65

3.1

2.3

2352.1

5144.4

umol/l

18.98

13548

49221

(3024561) Albumin [Mass/volume] in Serum or Plasma

24993

90380

2.59

307.65

6.4

4.1

35.2

36.0

g/l

89.52

23438

83325

(3022096) Basophils/100 leukocytes in Blood

24724

100499

2.18

307.65

7.8

5.6

0.7

7.52

23223

93510

(3013512) EKG study

13916

63717

1.56

307.65

4.5

3.5

—

(3018095) Leukocytes [#/volume] in Urine

20211

75480

2.23

307.65

4.8

3.2

83.4

100.2

e6/l

1.64

15233

51787

(3026008) Bacteria identified in Urine by Culture

16176

61073

2.05

307.65

3.7

2.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

6430

16561

2.72

307.65

9.9

6.8

10.0

9.6

mmol/l

3.11

6119

15746

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4177

10541

2.69

307.65

1.9

1.5

—

(3026782) Osmolality of Urine

12259

39890

2.30

307.65

3.3

2.5

530.8

555.8

mosm/kgh2o

21.60

10714

33569

(3029937) Albumin [Presence] in Urine by Test strip

13348

59703

1.60

307.65

5.2

3.5

0.0

estimate

0.28

4808

19524

(3018418) pH of Serum or Plasma

17621

60350

2.37

307.65

5.4

3.5

7.4

5.28

3236

11434

(3033658) Prothrombin time (PT) actual/Normal

16592

52452

2.56

307.65

5.8

3.3

91.3

90.9

1.06

16151

51061

(3036489) Thrombin time

2655

7611

2.31

304.12

2.3

1.9

21.5

21.3

0.69

2363

6561

(3020891) Body temperature

2630

7528

2.32

302.24

5.6

4.6

—

(3019150) Specific gravity of Urine by Refractometry

10838

48772

1.55

297.49

5.0

3.5

1.0

kg/l

0.57

1355

7572

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2969

9117

2.16

288.65

3.8

2.5

1.5

1.2

15.45

2953

9070

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2140

5698

2.48

287.36

2.8

2.3

197.0

183.6

8.10

2025

5393

(3017181) Myelocytes/100 leukocytes in Blood

4856

17809

1.84

287.10

4.5

4.0

0.9

0.41

1500

4418

(3034860) Kappa light chains.free [Mass/volume] in Serum

2088

5501

2.50

286.56

3.4

2.6

55.5

67.2

mg/l

0.51

1679

4458

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2084

5489

2.50

286.16

3.4

2.6

40.3

42.3

mg/l

0.22

1678

4452

(3002179) Metamyelocytes/100 leukocytes in Blood

4495

16131

1.87

284.27

4.2

3.8

0.6

0.7

1.04

1139

3140

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2270

6257

2.40

283.16

2.4

2.1

90.7

92.0

1.54

2136

5772

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2059

5455

2.49

279.22

1.5

13.6

13.9

iu/ml

0.03

143

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

563

575

6.36

276.86

2.1

1.7

106.5

137.5

umol/l

1.11

293

272

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1685

4056

2.73

275.74

1.7

1.5

—

(3019225) pH of Specimen

5366

20536

1.76

274.98

5.4

3.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2015

5331

2.49

273.96

3.3

2.6

4.0

ratio

0.50

184

420

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2885

8941

2.14

273.71

3.8

2.5

0.7

1.44

2778

8550

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

17656

88911

1.43

272.61

4.8

3.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

2318

6562

2.33

272.46

4.5

4.1

1.4

mmol/l

0.31

2279

6442

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1603

3796

2.77

270.30

7.4

5.2

3065.9

1103.9

iu/ml

0.40

274

541

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2206

6156

2.36

267.59

1.7

0.2

g/l

4.37

2092

5832

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1626

3919

2.72

265.33

1.8

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2249

6358

2.34

265.01

1.7

1.6

1.2

g/l

13.15

2137

6047

(40760892) CBC W Ordered Manual Differential panel - Blood

11116

51466

1.50

262.02

5.3

4.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

4600

17044

1.81

261.77

4.5

4.1

0.1

0.44

1391

4109

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2701

8303

2.15

261.18

1.3

1.2

0.9

0.8

u/ml

0.04

243

652

(3025941) Bacteria identified in Stool by Culture

3590

12337

1.94

257.25

1.4

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2304

6715

2.27

253.05

3.7

3.2

1081.8

1797.5

u/ml

0.31

1969

5745

(3004119) Hemoglobin [Mass/volume] in Venous blood

3548

12266

1.93

249.53

4.2

3.0

126.7

131.3

g/l

23.72

3463

12017

(3025159) Blasts/100 leukocytes in Blood

4362

16129

1.81

249.24

4.5

4.1

0.0

0.3

3.51

1214

3435

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1287

2816

2.99

249.21

1.8

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1553

3792

2.69

247.12

1.6

1.5

—

(3000492) Spirometry study

5497

21907

1.69

241.82

1.6

1.4

—

(3010421) pH of Blood

1840

4950

2.44

241.12

4.7

3.5

7.4

5.47

1587

4108

(3034770) Mitochondria Ab [Titer] in Serum

2042

5776

2.33

239.89

1.2

836.7

1011.0

titre

0.42

200

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6547

27411

1.62

237.70

9.2

5.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

2061

5890

2.30

236.51

1.3

1.2

113.2

128.0

titre

0.36

165

568

(3027315) Oxygen [Partial pressure] in Blood

1645

4248

2.54

234.49

4.6

3.6

8.5

8.7

kpa

1.92

1596

4136

(3012501) Base excess in Blood by calculation

1632

4218

2.54

232.21

4.6

3.6

2.6

2.4

mmol/l

0.82

1101

2826

(3013290) Carbon dioxide [Partial pressure] in Blood

1632

4220

2.54

231.98

4.6

3.6

5.0

kpa

1.73

1583

4109

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4343

16372

1.77

231.90

1.5

—

(1616796) Gas panel - Central venous blood

1607

4190

2.51

224.53

4.1

3.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

14982

75169

1.41

224.12

4.9

4.6

2.9

2.8

ug/l

0.28

13375

67858

(3026470) Cobalt [Mass/volume] in Blood

592

800

4.80

221.07

2.1

1.9

3.9

3.5

ug/l

0.34

522

700

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1753

4806

2.39

220.35

3.3

2.8

24.6

24.7

mmol/l

0.32

1531

4234

(3014765) Yersinia sp identified in Stool by Organism specific culture

2032

5949

2.25

220.27

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2017

5905

2.25

218.63

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

2030

5962

2.24

218.39

1.2

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

1963

5711

2.26

215.87

4.8

4.4

3.9

mmol/l

0.17

1859

5346

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2515

8086

2.05

215.67

2.2

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

1554

4075

2.50

214.50

3.5

2.7

—

(3025577) Chromium [Mass/volume] in Blood

573

774

4.80

214.07

2.1

2.0

2.3

2.4

ug/l

0.19

489

655

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1010

2111

3.12

210.77

1.6

1.5

56.9

56.0

0.24

651

1330

(3011288) Drugs identified in Urine by Screen method

1889

5464

2.27

210.46

5.4

2.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1303

3177

2.68

207.59

1.5

1.6

0.7

0.8

g/l

4.09

1004

2383

(3028626) Oxygen [Partial pressure] in Capillary blood

1533

4066

2.47

206.58

3.1

2.6

8.1

8.2

kpa

0.68

1425

3765

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2325

7374

2.08

206.46

2.1

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1034

2223

3.03

206.00

1.7

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1494

3945

2.48

203.16

1.6

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

35429

205817

1.39

202.12

27.8

13.3

14.0

13.6

307.65

34946

200994

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1115

2538

2.87

201.41

2.8

2.7

1105.3

737.0

u/ml

0.17

1098

2423

(40767503) Oxygen content in Capillary blood by calculation

1499

3997

2.46

199.70

2.9

2.3

16.3

16.7

2.69

803

2088

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1527

4131

2.42

197.27

1.5

—

(3037756) Immunofixation for Serum or Plasma

1387

3586

2.53

196.90

1.8

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1208

2935

2.69

193.66

3.2

2.5

1487.6

5468.5

u/ml

0.55

152

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4325

17111

1.69

192.77

2.6

2.1

12.4

12.9

nmol/l

3.81

3753

15363

(4035726)

4534

18183

1.66

191.98

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1789

5279

2.22

189.92

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

2093

6619

2.08

186.91

3.2

3.0

0.4

0.3

g/l

1.31

964

2799

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1798

5359

2.20

186.30

3.8

2.7

1.7

1.5

mg/l

26.20

1652

4926

(3002256) Pathology report gross observation

6789

30239

1.51

183.83

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

488

656

4.82

183.31

3.3

2.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2644

9254

1.88

177.26

1.9

2.0

39.4

39.5

u/l

0.02

2337

8274

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1205

3087

2.55

174.11

1.6

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2092

6795

2.02

173.75

1.4

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

3625

14047

1.71

173.45

1.4

1.3

226.4

235.1

u/ml

0.17

3344

13038

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4287

17401

1.64

172.22

5.3

3.1

1.2

mmol/l

4.51

3815

15027

(3023419) Bacteria identified in Sputum by Culture

947

2152

2.86

171.46

2.5

2.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2034

6571

2.03

171.38

1.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1980

6364

2.04

169.10

1.6

3.9

8.3

iu/ml

0.46

429

1299

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

852

1841

3.01

168.22

1.8

1.5

—

(36660697) Celiac disease serology panel - Serum

4319

17667

1.63

168.05

1.2

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3910

15629

1.66

166.42

2.4

2.3

28.2

24.1

au/ml

0.90

158

1035

(3028271) Lactate [Moles/volume] in Capillary blood

1141

2911

2.56

166.19

2.1

1.7

1.8

mmol/l

0.90

1114

2831

(1001926) Buprenorphine [Presence] in Urine by Screen method

2011

6554

2.01

165.35

4.0

1.9

—

(3026250) Tacrolimus [Mass/volume] in Blood

516

796

4.20

165.24

39.0

33.8

7.4

7.3

ug/l

0.27

464

728

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3605

14201

1.68

161.94

1.3

51.6

49.2

au/ml

0.16

105

640

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

12313

62379

1.36

161.50

1.7

1.6

1.5

1.3

mmol/l

78.67

10466

52554

(3003181) Sodium [Moles/volume] in Urine

1156

3015

2.50

160.99

1.5

1.3

59.9

63.6

mmol/l

1.95

899

2401

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

763

1585

3.13

160.72

1.2

135.0

203.5

titre

1.54

133

263

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

761

1579

3.13

160.60

1.2

158.9

206.6

titre

0.25

(3021901) Oxygen saturation in Capillary blood

1278

3503

2.38

160.22

3.1

2.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7415

34507

1.45

159.06

1.8

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

777

1650

3.06

157.90

3.6

3.8

—

(3045414) Leukocytes [Presence] in Urine

2662

9694

1.81

157.04

2.0

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1369

3920

2.28

155.60

1.3

1.2

121.7

116.0

titre

0.05

(3049717) Cytology report of Urine Cyto stain

2238

7747

1.90

154.64

2.5

2.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1501

4483

2.19

154.42

2.4

2.0

129.5

132.2

g/l

2.96

1043

3313

(3008898) HLA-B27 [Presence]

2151

7360

1.92

153.83

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1410

4125

2.23

152.41

1.5

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

969

2395

2.63

150.17

1.6

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

8651

41789

1.40

149.91

1.9

1.8

—

(3010375) cycloSPORINE [Mass/volume] in Blood

485

776

4.05

148.42

29.5

26.0

117.2

114.0

ug/l

0.42

383

642

(21494755) Public health laboratory ask at order entry panel

2823

29395

0.59

147.08

1.4

1.3

—

(3051651) Icteric interference index of Serum or Plasma

559

1003

3.61

146.80

4.5

3.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1134

3087

2.39

144.22

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

3786

15566

1.61

143.17

3.1

2.7

4.3

4.0

e9/l

6.58

2857

12163

(4198724)

491

820

3.88

142.17

3.4

1.9

—

(1761868) Lipid panel - Serum or Plasma

12355

97217

0.75

141.53

3.0

2.7

—

(40768441) Liver Pathology biopsy report

633

1280

3.21

139.19

1.7

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1007

2638

2.48

138.89

1.5

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

925

2326

2.59

138.58

1.9

1.7

89.3

90.0

2.42

910

2289

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

902

2253

2.60

136.93

1.5

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

486

830

3.79

136.61

1.2

1.1

3.7

3.4

iu/ml

0.25

(3051611) Lipemic interference index of Serum or Plasma

827

1983

2.71

135.76

4.2

3.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

828

1994

2.70

134.82

1.4

2.8

3.2

g/l

6.57

589

1374

(44806118)

805

1910

2.74

134.76

1.7

1.4

—

(44790047)

805

1910

2.74

134.76

1.7

1.4

—

(44790048)

805

1910

2.74

134.76

1.7

1.4

—

(44790049)

805

1910

2.74

134.76

1.7

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3501

14324

1.62

134.69

3.0

3.4

4.4

4.5

pmol/l

8.32

3073

12790

(4062490)

829

2001

2.69

134.40

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

827

1995

2.69

134.22

1.4

6.6

6.9

g/l

1.56

592

1375

(3024139) IgG subclass 3 [Mass/volume] in Serum

826

1993

2.69

134.01

1.4

0.4

g/l

0.11

593

1377

(3020191) Ethanol [Moles/volume] in Serum or Plasma

711

1590

2.90

132.37

1.7

1.4

1.5

1.4

promille

1.25

542

1220

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

11654

59995

1.33

132.05

4.2

4.0

21.8

21.9

0.36

5158

28441

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

369

524

4.55

130.45

2.4

1.8

62.8

55.6

ug/l

0.71

364

508

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2882

11360

1.67

128.07

2.5

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

871

2212

2.56

127.94

1.6

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1029

2831

2.36

127.82

1.1

1.6

1.5

g/l

7.25

932

2564

(3010144) Erythrocytes [#/volume] in Synovial fluid

691

1552

2.89

127.68

1.4

109776.0

82302.2

e6/l

0.54

489

1061

(3047181) Lactate [Moles/volume] in Blood

1798

6162

1.91

127.59

6.3

5.5

1.3

mmol/l

0.07

1588

5426

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1097

3122

2.29

126.30

1.3

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1602

5296

1.98

126.15

1.3

540.8

518.2

mg/l

0.43

1524

5048

(3016879) Cocaine [Presence] in Urine

2215

8144

1.78

125.95

3.9

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

759

1811

2.72

125.75

1.7

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1207

3590

2.19

125.24

3.1

3.0

522.4

694.1

u/ml

0.32

1089

3233

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1761

6035

1.91

124.94

1.3

15.8

40.7

u/ml

5.85

398

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

830

2098

2.57

123.06

1.2

59.5

58.8

u/l

0.08

608

1366

(3042517) Benzodiazepines panel - Urine

195

145

8.67

122.83

3.5

2.9

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

718

1685

2.76

122.66

1.6

1.5

28.5

32.6

1.92

438

1059

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1338

4181

2.09

122.65

1.6

1.4

18.7

21.0

u/ml

0.26

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

707

1647

2.78

122.41

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

41442

252231

1.37

122.20

5.5

4.5

2.7

2.8

mmol/l

267.98

38266

234222

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

694

1625

2.77

119.05

3.2

2.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1047

2997

2.27

118.93

3.3

3.2

1.2

1.5

1.77

825

2278

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

542

1098

3.20

118.88

2.6

1.9

97.7

97.9

0.04

513

1018

(3007461) Platelets [#/volume] in Blood

45171

279457

1.52

118.74

34.0

16.0

256.0

250.8

e9/l

47.40

44462

271362

(3042631) Mycobacterium sp identified in Specimen

899

2405

2.43

118.63

2.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1338

4235

2.06

118.56

1.6

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1436

4672

2.01

118.14

2.1

1.8

196.4

200.7

pmol/l

0.73

1329

4453

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1318

4155

2.07

118.03

1.3

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2554

9966

1.68

117.59

4.3

3.1

25.1

25.3

mmol/l

1.20

2462

9686

(40761536) Microorganisms panel - Urine sediment

4264

18821

1.50

116.57

5.2

3.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

573

1217

3.05

116.45

1.6

1.4

—

(3035941) MCH [Entitic mass]

45181

279703

1.51

115.52

33.8

15.9

30.3

9.28

44782

275327

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

843

2218

2.47

115.20

1.2

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1424

4664

1.99

114.99

1.2

3.8

mmol/l

1.56

1319

4390

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2399

9265

1.70

114.67

4.8

3.6

50.9

47.3

9.09

2369

9175

(3010813) Leukocytes [#/volume] in Blood

45191

279825

1.51

114.64

34.0

16.0

7.1

6.6

e9/l

323.01

44372

270919

(3024731) MCV [Entitic volume]

45181

279751

1.51

114.62

33.9

15.9

91.4

90.7

193.65

44777

275369

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1250

3906

2.08

114.53

1.3

1.2

300.4

265.8

u/ml

3.15

837

2550

(3026361) Erythrocytes [#/volume] in Blood

45182

279774

1.51

114.34

34.0

16.0

4.4

4.6

e12/l

307.65

44352

270885

(3048929) Epstein Barr virus Ab [Presence] in Serum

1812

6452

1.84

114.18

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1622

5588

1.90

113.15

1.3

9.3

7.2

u/ml

0.50

237

912

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

543

1136

3.10

113.13

1.3

1.2

96.5

87.5

u/l

0.99

471

988

(3000963) Hemoglobin [Mass/volume] in Blood

45184

279878

1.50

112.68

34.2

16.1

133.1

137.1

g/l

307.65

44788

275513

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2642

26356

0.62

112.66

1.8

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1234

3868

2.08

112.15

1.6

1.4

117.5

110.0

u/ml

0.83

257

920

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

530

1099

3.12

112.02

1.3

1.2

31.8

21.4

u/l

3.15

454

947

(3000764) Benzodiazepines [Presence] in Urine

2299

8836

1.71

111.78

3.9

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1601

5522

1.89

111.28

1.3

9.9

5.4

u/ml

0.78

157

605

(3028300) Cannabinoids [Presence] in Urine

2310

8917

1.70

110.52

3.9

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1393

4603

1.97

109.69

1.3

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

705

1740

2.63

109.55

1.4

1.3

1.5

1.4

nmol/l

1.99

640

1569

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2269

8738

1.70

109.48

1.1

9.0

4.7

u/ml

0.22

139

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1204

3773

2.08

109.48

4.3

2.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

543

1159

3.03

109.47

1.9

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

867

2369

2.38

109.31

1.6

1.4

—

(3042733) HLA Ab [Presence] in Serum

386

656

3.80

109.30

4.7

5.2

—

(3027008) Opiates [Presence] in Urine

2300

8901

1.69

108.99

3.7

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

891

2469

2.34

108.92

1.6

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1349

4420

1.99

108.77

1.2

3.9

13.1

u/ml

1.37

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

865

2368

2.37

108.61

1.6

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

775

10986

0.44

108.36

1.4

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

1334

4365

1.99

107.96

1.3

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1674

5917

1.85

107.88

2.0

2.1

11.4

10.6

mg/l

3.55

1554

5540

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

872

2407

2.35

107.51

1.6

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1406

4703

1.95

106.92

1.3

1.4

23.0

30.0

e6/l

0.33

1091

3629

(3025468) Yersinia sp identified in Specimen by Organism specific culture

861

2369

2.36

106.91

1.6

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

11992

63424

1.29

106.82

4.1

2.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1406

4711

1.95

106.39

1.4

1.5

1197.8

2822.1

e6/l

0.97

1143

3821

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1357

4491

1.97

106.37

1.3

1.2

4.8

6.5

u/ml

0.38

371

(21494890) Protein electrophoresis panel - 24 hour Urine

704

1765

2.59

106.10

2.2

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

869

2414

2.34

105.64

1.6

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

737

1898

2.52

105.26

3.4

3.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1055

3214

2.13

103.11

1.3

1.2

4.3

3.8

u/ml

0.58

463

1434

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1077

3322

2.11

102.00

1.3

1.2

3.0

3.8

u/ml

0.91

352

1175

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1116

3498

2.08

101.39

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

852

2394

2.31

100.95

2.3

1.9

24.7

27.2

mg/l

0.55

212

625

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

612

1464

2.71

100.95

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

612

1464

2.71

100.95

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

612

1464

2.71

100.95

1.6

—

(3044927) Protein electrophoresis panel - Urine

671

1686

2.58

100.70

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

651

1612

2.62

100.54

2.6

2.5

0.4

0.8

—

(40762814) Titanium [Mass/volume] in Blood

194

187

6.69

100.45

2.3

2.4

3.6

4.8

ug/l

0.75

(40768443) Skin Pathology biopsy report

2428

9826

1.62

96.62

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

801

2236

2.32

96.33

1.6

36.3

31.1

iu/ml

0.32

115

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2182

8601

1.66

96.28

5.6

4.6

1.8

1.6

5.96

2059

8087

(3003327) Ova and parasites identified in Stool by Light microscopy

1942

7424

1.71

96.01

1.8

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

39142

238139

1.28

94.88

4.4

3.7

1.5

1.3

mmol/l

307.65

35832

220391

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2111

8284

1.67

94.71

1.6

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

558

1318

2.74

94.27

1.6

1.4

—

(3027944) Amphetamines [Presence] in Urine

2211

8796

1.64

94.10

3.8

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

802

2264

2.30

94.04

1.5

1.4

32.6

32.5

g/l

0.03

717

2021

(3016650) Hepatitis A virus Ab [Presence] in Serum

1106

3565

2.02

93.23

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1035

3256

2.07

93.12

3.1

3.0

0.8

nmol/l

0.37

760

2486

(3012441) Differential panel - Pleural fluid

663

1722

2.49

93.09

1.5

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8473

43488

1.31

92.70

2.9

0.7

0.8

ug/l

7.17

5645

27745

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

40594

248372

1.30

91.85

5.0

4.1

4.5

4.7

mmol/l

262.15

37733

231926

(3023199) Leukocytes [#/volume] in Pleural fluid

733

2012

2.36

91.52

1.6

1.4

2602.8

3264.6

e6/l

0.56

516

1439

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

942

2877

2.13

91.47

1.3

0.2

nmol/l

0.34

164

(3028308) Erythrocytes [#/volume] in Pleural fluid

678

1798

2.44

91.17

1.6

1.4

54831.6

54868.0

e6/l

0.00

411

1050

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1687

17847

0.59

90.99

1.5

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

939

2887

2.11

89.65

1.3

1.5

1.6

nmol/l

0.03

901

2785

(3007930) Methemoglobin/Hemoglobin.total in Blood

2121

8460

1.64

89.27

5.8

4.6

0.9

0.10

2004

7949

(3017354) Segmented neutrophils/100 leukocytes in Blood

675

1811

2.42

88.56

3.3

3.1

60.3

57.3

2.44

457

1114

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

427

901

3.06

87.83

1.8

1.5

2382421.2

2109586.1

iu/ml

0.14

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1299

4524

1.87

87.51

1.3

1.2

42.4

41.3

u/ml

0.08

131

438

(3033799) Differential panel - Peritoneal fluid

293

481

3.93

86.95

2.1

1.8

—

(3008295) Osmolality of Serum or Plasma

663

1780

2.41

86.87

1.3

1.5

277.2

280.2

mosm/kgh2o

2.13

477

1400

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

332

599

3.58

86.69

1.3

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

40295

246698

1.29

86.62

4.9

4.1

1.4

1.5

mmol/l

320.79

37191

229542

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1783

6857

1.70

86.13

2.0

1.7

38.6

41.8

nmol/l

6.50

1731

6703

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

479

1096

2.83

85.77

1.5

1.4

6.7

5.8

u/l

0.69

405

916

(3004716) Salmonella sp identified in Stool by Organism specific culture

2673

11371

1.54

85.75

1.3

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1658

6260

1.73

85.57

1.4

10.0

10.2

u/l

0.32

1334

5153

(4306422)

1007

3254

2.01

84.30

1.2

—

(3024263) Appearance of Synovial fluid

427

928

2.97

83.63

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8325

43143

1.29

83.52

1.6

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

859

2623

2.12

83.46

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

453

1023

2.86

83.04

1.4

1.2

280.6

370.7

u/l

0.77

426

952

(3036670) Protein [Mass/volume] in Synovial fluid

269

430

4.04

82.63

1.3

1.2

40.7

38.8

g/l

1.08

150

245

(3013005) Retinol [Moles/volume] in Serum or Plasma

354

692

3.30

82.21

2.0

1.5

2.0

umol/l

0.73

328

646

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

459

1058

2.81

81.14

1.4

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

484

7350

0.42

80.45

1.5

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

418

918

2.94

80.44

3.0

1.6

—

(3039000) Anion gap in Blood

1241

4376

1.84

80.41

7.4

6.4

11.1

11.3

mmol/l

1.19

1138

3931

(3018572) Chloride [Moles/volume] in Blood

1241

4377

1.84

80.35

7.4

6.4

105.0

105.3

mmol/l

0.99

1138

3932

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

463

1079

2.77

80.24

1.4

1.3

—

(40768806) Pleura Pathology biopsy report

638

1747

2.37

80.12

1.6

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

135

111

7.84

79.30

1.3

1.1

5.9

6.3

mmol/l

0.19

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

703

2022

2.25

79.00

1.9

1.8

25.8

22.1

ug/l

0.72

687

1977

(3014271) Vancomycin [Susceptibility]

376

787

3.09

78.42

3.2

2.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

727

2142

2.20

77.17

3.2

3.4

6.9

7.2

nmol/l

0.05

704

2083

(3011985) Renin [Units/volume] in Plasma

902

2895

2.02

76.93

1.4

1.6

75.4

60.2

mu/l

0.90

800

2604

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

958

3144

1.98

76.83

1.1

121.8

116.8

4.28

877

2836

(3045788) Cell count panel - Pleural fluid

579

1547

2.42

76.69

1.6

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

377

803

3.03

76.42

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

576

1539

2.42

76.30

2.1

1.9

2.1

0.9

g/24h

1.53

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

377

804

3.03

76.26

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

1293

4706

1.79

75.62

2.4

1.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

312

603

3.34

73.77

2.3

1.8

5471.0

3063.9

e6/l

0.32

202

409

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

975

3268

1.94

73.63

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2675

11751

1.49

73.50

3.4

2.5

0.3

e6/l

0.36

2605

11411

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

232

363

4.12

73.27

1.6

0.4

ug/l

1.12

167

223

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

580

1587

2.37

73.00

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

579

1585

2.36

72.80

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

580

1589

2.36

72.80

1.2

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

482

1210

2.58

72.58

2.9

25.7

27.0

ug/l

0.10

(3024471) HLA-A [Type]

333

679

3.17

72.48

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

751

2301

2.11

72.38

1.2

1.1

95.6

96.0

0.11

708

2156

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

285

525

3.50

72.34

2.2

1.7

6329.7

9231.6

e6/l

0.39

152

268

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

582

1604

2.35

72.10

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

581

1601

2.35

72.00

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

581

1602

2.35

71.90

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

394

893

2.85

71.84

1.5

3.9

3.3

0.31

206

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

835

2677

2.02

71.44

1.3

1.4

289.8

289.7

pmol/l

0.00

645

2083

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

614

1742

2.28

71.26

1.1

—

(3011412) CD3 cells [#/volume] in Blood

645

1870

2.23

71.18

2.1

2.4

1.3

1.1

e9/l

1.75

395

1113

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5638

28273

1.32

71.01

4.9

4.3

31.4

32.2

5.65

4112

19341

(3024932) HLA-DR beta [Type]

324

663

3.16

70.15

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3345

15485

1.42

69.73

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

333

696

3.09

69.68

2.0

1.5

28.0

30.0

umol/l

3.01

324

665

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1364

5166

1.72

69.53

2.4

156.8

95.8

ug/min

3.31

790

3113

(21491868) Cryoglobulin [Mass/volume] in Serum

316

646

3.16

68.53

1.2

0.9

0.4

g/l

0.75

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

212

326

4.19

68.44

1.3

1.2

—

(3045716) Anion gap in Serum or Plasma

365

822

2.87

67.34

2.8

2.4

9.2

mmol/l

0.10

271

593

(3042111) Morphology [Interpretation] in Bone marrow Narrative

906

3060

1.92

66.92

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

471

1221

2.49

66.52

1.7

1.5

6.9

5.8

u/l

0.67

253

556

(3009542) Hematocrit [Volume Fraction] of Blood

37642

230345

1.22

66.22

25.0

11.8

39.5

40.2

44.72

26748

172136

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

729

2287

2.06

66.12

1.2

1.1

1.0

2.1

iu/ml

2.32

(3023410) Appearance of Cerebral spinal fluid

687

2118

2.10

65.21

1.5

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

643

1934

2.15

64.96

1.4

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

867

2918

1.93

64.72

1.4

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

334

5395

0.39

64.41

1.5

—

(3022621) pH of Urine by Test strip

3155

14666

1.41

64.05

3.3

2.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

565

1620

2.26

64.04

1.1

295.4

473.8

mg/l

0.48

502

1457

(3000093) Morphology [Interpretation] in Blood Narrative

629

1888

2.16

63.87

1.1

—

(3016038) Potassium [Moles/volume] in Urine

441

1130

2.52

63.81

1.3

1.1

32.7

34.1

mmol/l

0.58

369

990

(3045424) Erythrocytes [Presence] in Urine

1037

3725

1.81

63.32

1.6

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

405

999

2.62

63.20

2.1

26.0

17.1

umol/l

0.75

(40768446) Kidney Pathology biopsy report

348

792

2.84

63.06

1.8

1.6

—

(3047189) Immunofixation for 24 hour Urine

328

722

2.93

63.00

1.9

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

786

2590

1.97

62.36

1.3

—

(4268621)

701

2216

2.05

62.33

2.5

2.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

382

921

2.68

62.28

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

380

914

2.69

62.24

1.6

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

569

1662

2.21

61.75

1.2

1.1

58.2

59.5

u/ml

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1208

4579

1.71

61.37

2.9

1.8

0.9

0.8

nmol/l

6.34

994

3866

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

443

6240

0.45

60.47

1.4

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

447

1184

2.44

60.42

3.5

3.2

28.9

29.3

mu/l

0.06

421

1114

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

156

206

4.88

60.06

1.7

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

808

2732

1.92

59.53

1.3

1.2

46.3

54.2

u/ml

0.36

176

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

472

1293

2.36

59.35

1.3

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

476

1311

2.35

59.15

1.5

1.6

25.3

24.4

u/ml

0.12

280

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

413

5911

0.44

58.84

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

413

5906

0.44

58.71

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

412

5892

0.44

58.57

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

298

4847

0.39

58.41

1.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

411

5872

0.45

58.28

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

895

3152

1.84

58.24

1.2

47.3

30.3

u/l

1.63

797

2725

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

205

350

3.78

57.95

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

547

1620

2.18

57.45

1.3

6.4

6.3

mmol/l

0.33

505

1500

(3035320) C reactive protein [Mass/volume] in Body fluid

500

1432

2.26

56.88

3.2

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

643

2040

2.04

56.67

1.2

—

(3004451) EKG impression Narrative

352

856

2.65

56.52

1.4

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

270

567

3.07

56.18

1.7

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

527

1552

2.20

56.13

1.3

387.3

528.0

u/l

1.31

491

1464

(3019977) pH of Arterial blood

391

1008

2.51

55.95

3.1

2.3

7.4

0.52

145

353

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

288

631

2.95

55.83

1.9

8.6

9.6

mg/l

2.03

229

504

(3016018) Differential panel - Cerebral spinal fluid

699

2304

1.96

55.46

1.4

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

304

690

2.84

55.43

2.9

3.1

8.1

mg/l

0.02

238

551

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

679

2221

1.98

55.05

1.1

63.2

69.7

au/ml

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

110

111

6.38

54.96

2.0

1.6

47.6

49.5

umol/l

0.19

110

111

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

409

1089

2.43

54.73

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

27126

162384

1.17

54.72

3.2

2.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

363

912

2.57

54.72

2.3

1.8

148.0

143.7

0.44

342

852

(3020961) Endomysium IgA Ab [Titer] in Serum

2375

10808

1.43

54.04

1.1

127.7

214.8

titre

1.14

288

(3020717) Zinc [Moles/volume] in Serum or Plasma

368

937

2.54

54.02

1.8

1.3

18.0

28.7

umol/l

10.20

353

886

(3003694) ABO and Rh group [Type] in Blood

11849

66371

1.19

54.00

1.4

—

(3017569) Oxygen content in Arterial blood

344

847

2.62

53.96

2.2

2.1

—

(3044007) Cell count panel - Peritoneal fluid

245

497

3.18

53.92

2.1

1.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

692

2297

1.95

53.83

5.9

9.7

7.7

7.3

mmol/l

0.83

567

1871

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

477

1377

2.24

53.30

2.1

2.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

476

1379

2.23

52.75

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

353

892

2.55

52.63

1.8

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

353

892

2.55

52.63

1.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

353

892

2.55

52.63

1.8

1.7

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

459

1311

2.26

52.59

3.1

3.5

151.1

112.7

nmol/l

1.17

447

1293

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

464

1332

2.25

52.54

2.1

2.5

540.7

510.6

e6/l

0.61

386

1117

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

575

1804

2.06

52.24

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

445

1260

2.28

52.03

1.5

1.4

12.9

12.7

u/l

0.30

428

1219

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

403

1093

2.38

51.87

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

476

1389

2.21

51.87

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

340

850

2.58

51.79

3.6

3.8

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

240

495

3.13

51.47

1.6

144.5

137.0

au/ml

0.07

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

350

895

2.52

50.97

1.8

1.7

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

278

632

2.84

50.60

2.4

2.6

140.5

158.2

au/ml

0.21

(3047352) Trisomy 18 risk [Likelihood] in Fetus

330

4852

0.43

50.47

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

353

913

2.50

50.24

2.2

2.1

160.7

107.0

ug/min

0.54

220

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

223

3852

0.37

50.18

1.4

—

(3005033) Fetal Nuchal fold Thickness US

330

4839

0.43

50.12

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

345

4972

0.44

50.07

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

247

529

3.01

49.82

1.8

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

550

1730

2.06

49.66

1.2

1.1

39.3

44.7

mg/l

1.38

467

1451

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

406

1130

2.32

49.38

1.3

67.3

70.9

titre

0.07

114

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

518

1609

2.08

48.35

1.3

2.0

2.1

mmol/l

0.73

477

1493

(3006922) Hepatitis E virus Ab [Presence] in Serum

499

1531

2.11

48.09

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

341

888

2.48

47.88

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

410

1163

2.28

47.79

1.3

735.5

340.5

titre

0.83

(3019420) Tryptase [Mass/volume] in Serum or Plasma

405

1143

2.29

47.76

1.6

1.5

9.4

7.8

ug/l

0.59

373

1025

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

481

1459

2.13

47.72

2.2

2.6

742.1

672.9

e6/l

0.78

190

581

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

527

1660

2.05

47.43

1.1

279.8

272.1

mg/l

0.23

458

1456

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

420

1210

2.24

47.23

1.3

12.1

15.1

u/l

2.20

389

1113

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

301

743

2.61

47.06

2.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

491

1510

2.10

47.04

2.1

2.0

74.5

72.5

2.24

472

1454

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

276

653

2.73

46.77

2.4

1.8

168.3

167.7

0.03

264

615

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

517

1627

2.05

46.65

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

451

1346

2.16

46.60

1.7

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

949

3639

1.69

46.28

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

383

1070

2.31

46.23

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

277

661

2.70

46.21

1.2

1.1

115.3

106.0

2.58

255

599

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

515

1625

2.05

46.15

1.6

2.0

17.7

17.9

nmol/l

0.22

480

1542

(3029634) Reagin Ab [Titer] in Serum by VDRL

845

3140

1.74

46.11

2.2

9.1

8.0

titre

0.11

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

436

1289

2.18

46.11

2.2

2.5

0.2

e9/l

0.69

381

1112

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

605

2027

1.93

45.89

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

193

374

3.33

45.68

1.4

1.3

32.2

26.3

g/l

0.32

134

296

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

175

318

3.55

45.51

4.8

5.8

—

(3038026) Centromere Ab [Units/volume] in Serum

525

1679

2.02

45.39

1.2

40.4

46.0

u/ml

0.12

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

481

1490

2.09

45.26

2.0

13.7

15.1

1.34

233

662

(3045142) Bone marrow Pathology biopsy report

613

2074

1.91

45.18

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

339

907

2.41

45.01

1.7

1.6

19.7

6.1

nmol/l

0.41

277

767

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1394

5913

1.53

44.95

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

486

1516

2.07

44.91

1.3

1.0

u/ml

0.22

248

629

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

338

907

2.40

44.60

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

338

908

2.40

44.50

1.4

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

511

1634

2.02

44.21

1.2

65.1

64.4

u/ml

0.01

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

512

1639

2.02

44.17

1.2

52.6

42.3

u/ml

0.36

127

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

276

674

2.64

44.10

1.9

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

493

1558

2.04

44.03

1.2

11.7

6.4

u/ml

0.37

114

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

276

675

2.64

43.97

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

663

2324

1.85

43.89

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

255

600

2.74

43.70

2.0

1.6

48590.6

21656.1

u/ml

0.29

(3044242) Glucose [Moles/volume] in Arterial blood

326

874

2.41

43.12

2.2

1.9

—

(3010503) CD19 cells [#/volume] in Blood

401

1179

2.20

43.02

2.2

2.6

0.2

0.4

e9/l

1.10

388

1155

(3026692) Albumin [Mass/volume] in Peritoneal fluid

207

437

3.05

42.85

1.7

1.3

11.3

13.5

g/l

2.47

145

334

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

276

685

2.60

42.76

2.0

1.9

—

(3007463) Buprenorphine [Presence] in Urine

7.85

42.53

9.3

9.8

—

(21494815) CD4 cells/100 lymphocytes in Specimen

544

1811

1.94

42.08

2.1

42.2

41.1

0.20

233

(4146454)

634

2223

1.84

41.95

2.8

2.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

263

644

2.63

41.83

1.1

96.0

89.3

1.50

126

320

(3017704) Immunofixation for Urine

340

948

2.31

41.29

1.8

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

169

321

3.39

41.27

2.0

1.7

—

(4027681)

429

1324

2.09

40.81

1.3

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

266

670

2.56

40.07

1.1

92.0

89.8

0.45

123

330

(3002619) Bacteria identified in Specimen by Culture

173

341

3.27

39.97

1.4

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

636

2267

1.81

39.96

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1253

5328

1.53

39.96

1.3

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

459

1469

2.02

39.68

1.8

1.7

4.0

3.6

mg/l

0.75

435

1402

(3013166) Neutrophils/100 leukocytes in Synovial fluid

224

520

2.78

39.40

1.4

56.5

54.1

0.36

184

450

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

285

751

2.45

39.16

1.3

1.2

0.3

g/l

2.78

233

597

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

666

2432

1.77

38.66

1.1

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

196

427

2.96

38.56

1.4

1.3

39.7

0.00

137

288

(3028433) Virus identified in Specimen by Culture

240

587

2.64

38.32

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

212

486

2.81

38.17

1.2

—

(4015189)

205

462

2.86

38.04

2.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

673

2477

1.76

38.04

2.3

2.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

438

1401

2.02

37.95

2.0

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

394

1211

2.10

37.93

1.1

2.2

6.6

nmol/l

1.65

236

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

144

260

3.57

37.88

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

297

811

2.36

37.83

1.1

—

(1002224) Polysomnography panel

2186

10416

1.37

37.82

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

137

2598

0.34

37.77

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

385

1176

2.11

37.66

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1466

6522

1.46

37.50

1.4

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

954

3883

1.59

36.89

1.5

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

419

1333

2.03

36.86

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

391

1213

2.08

36.76

1.1

u/l

0.07

169

541

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

266

700

2.45

36.69

1.3

1.2

112.5

110.6

0.48

231

635

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

697

2620

1.72

36.62

1.6

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

208

483

2.78

36.61

1.5

1.2

17.2

16.8

umol/l

0.45

189

422

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2460

12014

1.33

36.19

1.1

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

303

853

2.29

36.09

4.5

5.6

1121.6

3184.9

mg/l

1.15

234

589

(3021387) Prolactin [Units/volume] in Serum or Plasma

1763

8172

1.40

36.02

1.6

1.7

311.6

307.4

mu/l

0.14

1603

7392

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

300

843

2.30

35.88

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

374

1155

2.09

35.60

2.2

2.7

936.3

1050.2

u/ml

0.56

368

1141

(3027923) C peptide [Moles/volume] in Serum or Plasma

362

1107

2.11

35.34

1.5

1.3

nmol/l

0.01

265

896

(21494434) Karyotype in Bone marrow

478

1624

1.90

34.93

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

132

239

3.56

34.64

2.2

2.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2439

11987

1.32

34.32

3.7

2.9

51.5

41.3

u/ml

1.22

2337

11592

(3010015) Selenium [Moles/volume] in Serum or Plasma

121

4.79

34.18

2.2

1.7

1.3

1.4

umol/l

1.30

(3025315) Body weight

103

156

4.25

34.13

5.1

4.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

14.29

33.47

1.6

156.0

369.7

nmol/l

0.80

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1211

5320

1.47

33.06

2.1

1.6

—

(4034850)

1614

7481

1.40

32.99

14.3

7.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

207

508

2.63

32.92

1.5

1.2

138.7

128.0

nmol/l

0.33

159

377

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

282

804

2.26

32.69

1.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.19

32.67

3.0

—

(3036603) Volume of Urine

424

1420

1.93

32.37

1.6

1716.2

1998.8

1.93

355

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

481

1680

1.85

32.35

1.2

—

(3012565) Volume of 24 hour Urine

338

1044

2.09

32.22

2.3

2.1

1875.1

2031.6

1.32

308

926

(4024509)

527

1907

1.78

31.64

1.7

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

175

403

2.80

31.36

1.2

1.1

81.0

72.6

0.87

116

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

174

403

2.78

30.87

1.3

1.1

96.1

84.4

1.75

121

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

392

1301

1.94

30.76

1.1

10.7

8.8

iu/ml

0.47

333

(3020491) Glucose [Moles/volume] in Blood

459

1608

1.84

30.62

1.8

1.7

7.4

6.6

mmol/l

5.41

340

1138

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

178

420

2.73

30.53

1.2

115.2

105.9

2.49

170

397

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

879

3672

1.55

30.46

1.1

245.3

1273.3

iu/ml

1.14

187

743

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

456

1597

1.84

30.45

1.4

13.0

11.8

umol/l

3.06

434

1519

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

756

3056

1.60

30.16

1.2

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

117

4.57

29.96

2.7

2.5

2.1

2.3

mg/l

0.61

(3000034) Microalbumin [Mass/volume] in Urine

528

1945

1.75

29.88

3.2

2.9

58.7

51.3

mg/l

0.25

402

1367

(3034426) Prothrombin time (PT)

250

705

2.29

29.77

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

229

622

2.37

29.65

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

781

3197

1.58

29.57

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

823

3412

1.56

29.51

4.5

5.4

338.8

377.5

umol/l

11.70

695

2956

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1240

5595

1.44

29.49

1.7

1.9

19.2

10.6

iu/l

0.34

402

2148

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

277

820

2.18

29.43

3.1

2.1

—

(40762365) Oxygen content in Arterial blood by calculation

138

288

3.09

29.29

3.4

2.3

14.6

15.0

ml/dl

0.75

125

269

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3167

16434

1.26

29.12

1.2

119.1

149.0

iu/ml

4.02

1097

6416

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

681

2713

1.62

28.85

1.8

1.9

4696.3

4243.1

titre

0.09

130

(3029075) Extractable nuclear Ab panel - Serum

220

595

2.38

28.77

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

114

213

3.45

28.69

1.3

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

142

4.08

28.44

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

182

452

2.59

28.37

1.2

268.5

301.3

pmol/l

0.64

127

339

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

336

1088

1.99

28.31

1.6

1.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

107

194

3.55

28.12

1.4

1.6

95.2

111.9

ug/l

0.80

149

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

401

1384

1.87

28.07

1.2

—

(4281824)

599

2328

1.66

27.97

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

315

1001

2.03

27.95

1.1

—

(4094501)

1358

6290

1.40

27.90

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

251

732

2.21

27.69

2.0

2.1

8.9

10.1

0.87

235

678

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

402

1396

1.86

27.62

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

144

321

2.89

27.40

2.8

2.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

247

720

2.21

27.28

2.0

29.3

29.0

0.12

237

679

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

171

423

2.60

26.89

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

707

2917

1.57

25.95

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

156

376

2.67

25.81

1.7

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

272

845

2.07

25.68

2.4

53.8

52.8

umol/l

0.16

216

711

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

354

1213

1.88

25.39

2.6

2.8

41.9

38.7

1.31

115

403

(3037556) Urate [Mass/volume] in Serum or Plasma

194

526

2.38

25.31

1.4

1.3

—

(3036180) Methadone [Presence] in Urine

10.07

25.12

3.4

1.8

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

130

4.01

25.11

1.6

1.5

3.1

4.2

mg/l

0.57

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

130

4.01

25.11

1.6

1.5

2.6

2.2

mg/l

0.16

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

130

4.01

25.11

1.6

1.5

2.9

1.8

mg/l

0.81

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

130

4.01

25.11

1.6

1.5

2.3

3.0

mg/l

0.32

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

130

4.01

25.11

1.6

1.5

1.7

2.6

mg/l

0.77

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

130

4.01

25.11

1.6

1.5

1.3

0.9

mg/l

0.34

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

130

4.01

25.11

1.6

1.5

2.2

mg/l

0.59

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

130

4.01

25.11

1.6

1.5

3.3

1.7

mg/l

0.95

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

130

4.01

25.11

1.6

1.5

1.7

mg/l

0.08

(3006576) Bicarbonate [Moles/volume] in Blood

238

708

2.17

25.08

6.7

6.3

24.6

25.2

mmol/l

1.40

227

638

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

133

3.97

25.08

1.6

2.6

2.0

mg/l

0.37

(3035880) pH of Pleural fluid

289

927

2.01

25.07

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

139

3.84

24.37

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

188

515

2.35

24.01

2.0

979.1

1003.4

e6/l

0.01

113

260

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

112

4.19

23.94

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

126

283

2.87

23.74

1.2

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

208

601

2.23

23.55

1.6

10.2

8.6

ug/l

4.18

208

601

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

117

253

2.98

23.53

1.3

1.5

7.4

148605.5

nmol/l

1.49

214

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

202

577

2.26

23.49

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

307

1032

1.92

23.37

4.9

7.5

1213.8

3762.6

u/ml

0.49

273

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

198

563

2.27

23.28

3.7

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

198

563

2.27

23.28

3.7

2.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

853

3756

1.47

23.14

1.4

1.3

28.1

u/l

0.01

696

3074

(3047007) Chlamydophila sp Ab [Presence] in Serum

759

3265

1.50

23.10

1.3

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

318

1091

1.88

22.79

1.1

32.6

20.1

u/l

2.60

238

830

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

184

3.32

22.77

1.8

1.6

1.7

mg/l

0.15

151

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

178

3.36

22.70

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

160

418

2.47

22.65

1.1

0.8

4.1

umol/24h

0.49

213

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

317

1090

1.87

22.57

1.1

99.0

79.1

u/l

2.21

254

854

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

374

1356

1.78

22.49

1.1

1.2

1.1

ratio

0.15

117

473

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

210

623

2.17

22.35

2.1

2.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

141

349

2.60

22.25

2.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

267

873

1.97

22.04

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

143

360

2.56

21.84

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

162

3.42

21.51

1.2

1.1

55.5

43.7

mg/l

0.80

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

240

766

2.02

21.20

2.5

3.0

27.8

28.9

umol/l

0.58

176

590

(3001019) Free T4 and TSH panel - Serum or Plasma

1771

14386

0.78

20.77

1.7

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4894

27321

1.17

20.72

1.6

1.7

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

141

3.56

20.71

2.8

2.1

57.3

62.8

0.45

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

158

3.38

20.47

1.3

1.7

ml/s/173m2

0.27

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

103

225

2.95

20.43

1.7

1.4

81.8

32.0

u/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4306

23834

1.18

20.26

2.0

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

305

1074

1.83

20.23

1.5

1.6

6.6

5.7

mmol/24h

0.43

(40757373) Influenza virus identified in Isolate

141

367

2.47

20.18

1.9

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1345

6553

1.33

20.14

1.1

4.2

5.6

u/ml

0.86

113

961

(37021550) Renin [Units/volume] in Plasma --upright

150

403

2.40

20.08

1.3

1.4

75.6

65.2

mu/l

0.28

105

301

(3016228) CD19 cells/100 cells in Blood

246

812

1.95

19.83

2.2

2.0

8.0

8.6

0.35

238

795

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

198

605

2.11

19.66

2.4

3.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

375

1417

1.71

19.62

11.5

12.3

0.6

mmol/l

2.21

340

1302

(21494814) CD8 cells/100 lymphocytes in Specimen

241

796

1.95

19.41

2.1

2.0

—

(3003338) MCHC [Mass/volume]

34583

215795

1.10

19.37

30.1

13.9

331.2

333.0

g/l

225.13

34357

214019

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

185

3.10

19.20

2.1

2.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

162

3.26

19.15

1.1

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

165

473

2.25

19.14

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

266

913

1.88

19.14

8.6

8.4

—

(3028717) Thiamine [Mass/volume] in Blood

182

3.11

19.14

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

113

3.76

18.92

1.3

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

168

491

2.20

18.64

1.3

3.2

3.6

mmol/l

1.06

159

449

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

115

283

2.62

18.45

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.06

18.35

12.4

8.8

195.2

404.0

e6/l

0.52

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

175

524

2.15

18.32

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

359

1374

1.68

17.98

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

173

520

2.14

17.95

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1536

0.41

17.71

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

150

1990

0.48

17.64

17.2

18.4

1221.1

2586.8

nmol/l

0.96

140

1904

(3003129) Base excess in Capillary blood by calculation

167

501

2.15

17.43

2.1

1.6

1.1

0.3

mmol/l

1.35

158

471

(3012898) Urea [Moles/volume] in Urine

211

2.84

17.36

1.4

1.6

161.3

173.7

mmol/l

0.39

189

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4715

26594

1.15

17.27

2.1

2.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

311

1158

1.73

17.23

1.9

1.7

2.2

2.4

u/field

0.27

226

829

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

172

525

2.11

17.20

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

146

417

2.25

17.15

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

123

326

2.43

17.04

2.8

2.5

66.3

43.1

mg/l

0.35

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

108

269

2.58

16.97

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

141

1883

0.48

16.93

13.2

13.0

750.4

1373.2

nmol/l

0.62

132

1816

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

771

3542

1.41

16.79

1.1

10.0

11.2

au/ml

0.17

242

(3013247) Albumin in CSF/Albumin in Serum or Plasma

156

463

2.17

16.74

1.1

7.4

7.0

mg/g

0.22

145

437

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

162

490

2.13

16.59

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.89

16.53

4.2

3.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

188

603

2.01

16.52

1.2

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

241

842

1.84

16.51

1.1

602.7

648.4

ng/l

0.04

204

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

175

2.98

16.47

3.3

3.0

1.5

1.3

mg/l

0.26

117

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

149

437

2.20

16.46

1.2

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

290

1074

1.74

16.40

1.2

1.3

69.4

62.8

0.46

118

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

109

278

2.52

16.36

1.5

1.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

190

615

1.99

16.30

1.4

57.5

63.0

1.22

153

499

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

171

534

2.06

16.16

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

112

292

2.47

16.09

5.5

5.1

56.9

40.4

ug/min

1.60

231

(3000012) Reticulocyte production index

299

1124

1.71

16.05

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1088

9086

0.76

15.94

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

170

533

2.05

15.90

1.9

1.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

218

748

1.88

15.81

1.4

14.3

15.0

pmol/l

0.85

178

629

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

123

338

2.34

15.80

1.3

1.4

742.5

117.8

ng/l

0.45

217

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

156

476

2.11

15.66

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

156

476

2.11

15.66

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

156

476

2.11

15.66

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

156

476

2.11

15.66

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

154

468

2.12

15.62

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

116

312

2.39

15.62

1.5

1.8

62.6

49.3

pmol/l

0.43

258

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

265

972

1.76

15.52

2.0

2.4

21.0

300.0

ug/l

1.75

253

921

(3016750) Collection duration of Urine

325

1262

1.66

15.51

2.2

505.8

495.2

min

0.97

223

972

(3019897) Erythrocyte distribution width [Ratio] by Automated count

387

3827

0.65

15.49

3.6

2.4

13.4

13.1

6.30

380

3776

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

133

382

2.24

15.47

5.3

6.2

67.1

72.9

1.54

105

301

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

115

311

2.38

15.32

1.0

82.7

83.0

ug/l

0.02

253

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

158

489

2.08

15.31

1.1

—

(44813793)

392

1608

1.57

15.01

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

215

2.66

14.89

2.1

2.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

276

1040

1.71

14.75

1.1

1.2

15.3

8.6

u/ml

0.27

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

116

3.33

14.58

2.9

2.0

13.7

16.9

0.30

(3052592) Norovirus Ag [Presence] in Stool

121

343

2.27

14.55

1.5

1.3

—

(4211845)

289

1109

1.68

14.46

3.3

2.8

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

134

399

2.16

14.35

1.4

23.9

22.7

0.17

108

327

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

109

297

2.36

14.32

2.6

5.6

70.3

44.0

u/l

0.32

124

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.29

14.29

24.9

15.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

217

771

1.81

14.18

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

132

394

2.16

14.06

2.7

2.3

7.8

7.4

mmol/l

0.37

242

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

355

1447

1.58

14.01

1.3

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

145

450

2.07

14.00

1.3

66.1

238.1

ug/l

1.39

233

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

212

754

1.81

13.82

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

201

704

1.84

13.76

1.7

2.2

1.0

ug/l

0.17

192

661

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1586

8286

1.24

13.75

2.5

2.2

4057.9

5509.6

u/l

1.19

491

3345

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

112

3.27

13.55

5.9

5.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

147

465

2.04

13.52

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

4.63

13.39

1.1

5.1

5.2

mmol/l

0.06

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

138

1711

0.52

13.34

1.4

1.6

9.1

7.6

mmol/l

3.30

1037

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

126

379

2.14

13.20

1.2

1.7

—

(3006462) Nitrate [Presence] in Urine

264

1015

1.68

13.17

3.3

2.9

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

206

2.56

12.80

6.7

7.7

0.3

0.5

umol/l

0.51

187

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5774

40858

0.90

12.62

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

200

721

1.79

12.53

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

211

777

1.75

12.32

1.5

1.4

73.7

72.6

0.50

203

742

(3006442) Creatine [Moles/volume] in Serum or Plasma

376

1603

1.51

12.23

1.7

1.4

69.6

70.8

umol/l

0.11

130

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

102

292

2.25

12.08

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

100

284

2.27

12.06

1.1

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

207

763

1.75

12.06

1.5

1.4

639.6

791.8

mu/l

0.35

199

728

(3005011) Chlamydia sp Ab [Titer] in Serum

256

2.34

12.03

1.7

—

(3048879) Bone marrow aspiration report

155

523

1.91

11.96

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

266

2.30

11.84

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

136

441

1.98

11.77

12.9

8.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

500

1.92

11.70

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

290

1180

1.58

11.63

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

253

997

1.63

11.56

1.1

101.6

96.7

1.54

199

784

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.88

11.49

1.0

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

120

375

2.06

11.48

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.71

11.39

8.6

8.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

130

2.87

11.22

1.2

1.3

85.4

100.1

ug/l

0.36

(3001893) Eosinophils/100 leukocytes in Pleural fluid

156

540

1.86

11.19

1.4

2.9

2.5

0.26

134

449

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

186

680

1.76

11.19

1.1

1.2

18.4

19.6

0.06

113

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

199

743

1.72

11.13

1.1

—

(3013466) aPTT in Blood by Coagulation assay

118

2.94

10.92

1.1

35.0

37.8

2.33

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.16

10.90

1.0

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

147

506

1.87

10.75

12.4

8.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

178

2.53

10.74

2.8

2.2

0.7

1.2

mmol/l

1.81

123

(3006270) Folate [Moles/volume] in Blood

415

1855

1.44

10.73

1.2

1.1

371.0

369.4

nmol/l

0.05

358

1558

(3036048) Francisella tularensis Ab [Titer] in Serum

141

479

1.89

10.73

1.1

1.2

248.0

532.0

titre

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

524

2442

1.38

10.70

1.3

1.2

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

4.55

10.62

1.4

139.2

99.0

ug/l

0.45

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.18

10.55

1.0

1.1

u/field

0.04

(3021162) Amylase [Enzymatic activity/volume] in Specimen

293

2.15

10.53

2.4

2.7

2146.2

1468.0

u/l

0.29

267

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1050

5408

1.25

10.45

1.5

1.4

163.0

110.7

pmol/l

2.13

1016

5293

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

263

1077

1.57

10.33

1.1

3.9

9.3

u/ml

3.19

189

(3051339) Copper [Moles/volume] in Blood

3.08

10.28

1.5

1.2

16.9

16.8

umol/l

0.04

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

4.03

10.20

1.1

1.0

0.2

g/l

1.47

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

154

549

1.81

10.12

1.7

2.0

38.0

37.4

u/l

0.01

138

496

(3007916) DNA double strand Ab [Titer] in Serum

265

2.19

10.06

1.2

1.4

68.0

128.5

titre

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

233

934

1.61

10.02

3.1

3.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2250

12509

1.16

9.98

1.4

1.3

26.9

30.0

iu/l

4.47

1896

10965

(3027570) Oxalate [Moles/time] in 24 hour Urine

121

2.82

9.98

1.5

1.4

436.2

308.0

umol/24h

1.92

121

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

4.39

9.87

9.2

7.9

41.7

48.9

0.56

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.99

9.75

1.1

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

269

2.15

9.72

2.7

2.9

—

(3014891) Appearance of Pleural fluid

240

2.22

9.70

1.7

1.6

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.18

9.65

1.1

1.5

178.1

191.7

ug/g

0.19

(3012920) Ethanol [Mass/volume] in Serum or Plasma

4.73

9.57

1.1

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

582

2813

1.33

9.48

1.5

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

272

2.13

9.47

1.4

1.2

0.2

0.3

nmol/l

1.15

185

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

100

316

2.04

9.39

1.1

2.5

9.0

pmol/l

0.61

(3004775) Volume in Urine collected for unspecified duration

394

1792

1.42

9.34

2.3

749.1

656.1

3.14

258

1236

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

274

2.11

9.31

1.3

1.4

13.4

12.4

0.11

128

(40768795) Lymph node Pathology biopsy report

460

2153

1.38

9.23

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

119

404

1.90

9.15

1.3

1.2

77.2

25.1

mg/l

0.55

298

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

243

2.17

9.07

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

245

1022

1.54

8.96

1.2

1.1

1560.0

1501.5

miu/ml

0.33

245

1022

(3000330) Specific gravity of Urine by Test strip

2075

11578

1.16

8.81

3.8

3.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

732

3690

1.28

8.80

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

213

2.23

8.79

1.1

1.9

3.4

umol/24h

0.41

213

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

303

2.02

8.74

1.1

0.0

0.5

u/ml

1.85

191

(3000919) Neutrophils/100 leukocytes in Pleural fluid

135

485

1.79

8.73

1.4

25.3

20.7

0.98

124

440

(3001686) Cold agglutinin [Titer] in Serum or Plasma

112

379

1.90

8.72

1.4

1.3

32.4

215.7

titre

1.67

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

210

2.24

8.69

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

390

1796

1.40

8.66

2.1

1.9

2.0

2.3

u/field

0.32

199

715

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

190

2.30

8.65

2.3

22.2

22.0

mg/l

0.02

176

(3003740) Influenza virus B Ag [Presence] in Specimen

731

3693

1.28

8.64

1.1

—

(4212803)

159

2.43

8.56

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

200

807

1.60

8.46

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

190

2.27

8.26

1.1

—

(3022689) Creatine [Moles/volume] in Urine

167

649

1.66

8.22

1.5

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

207

2.21

8.21

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.86

8.19

1.6

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

107

1227

0.56

8.16

1.3

1.4

25.4

31.0

nmol/l

1.00

1119

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

340

3037

0.72

8.13

1.7

1.3

2.7

3.5

ug/l

0.86

281

2643

(44786800) Granulocytes/100 leukocytes in Body fluid

200

2.22

8.10

1.3

24.3

27.3

0.29

147

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

255

2.07

8.10

3.1

3.2

41.6

42.3

umol/l

0.09

218

(3020123) Porphyrins [Interpretation] in Serum or Plasma

121

2.60

8.07

1.2

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.44

8.05

1.0

1.1

1.0

u/field

0.05

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

107

2.70

7.95

1.0

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

249

1073

1.49

7.90

1.5

1.2

3.9

4.8

umol/l

1.41

217

998

(44806071)

290

1.97

7.77

1.1

—

(40765096) Chromosome analysis panel by Banding

147

561

1.69

7.77

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

123

449

1.76

7.61

2.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

130

484

1.73

7.52

1.1

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.83

7.52

1.6

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

339

1.88

7.51

1.2

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

111

2.61

7.45

1.0

1.1

32.7

53.7

u/l

2.64

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

187

2.20

7.41

2.4

2.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

119

2.54

7.40

1.0

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.17

7.39

1.1

1.0

138.7

242.2

pmol/l

1.17

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

185

2.19

7.22

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

699

3597

1.25

7.18

1.5

1.4

0.3

0.4

nmol/l

1.72

530

2804

(3027035) Albumin [Mass/time] in 24 hour Urine

190

2.17

7.15

1.4

1.3

136.7

268.5

mg/24h

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

154

2.30

7.04

1.1

8.6

10.8

u/l

0.42

154

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1370

7543

1.17

7.00

1.3

188.8

224.7

miu/ml

3.18

534

3625

(3019832) Treponema pallidum Ab [Presence] in Serum

3136

22232

0.90

6.99

1.7

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

145

569

1.64

6.96

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.70

6.90

1.8

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

219

2.06

6.87

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

3.79

6.86

4.0

5.2

4.4

4.6

mg/l

0.05

(1761482) Bacteria [#/volume] in Urine by Culture

805

6283

0.82

6.77

5.6

3.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

125

2.42

6.74

1.3

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

125

2.42

6.74

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

148

589

1.62

6.73

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

318

1481

1.38

6.73

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

133

2.37

6.73

2.5

2.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

192

2.11

6.63

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

180

2.14

6.57

1.2

1.1

—

(3021374) Sirolimus [Mass/volume] in Blood

5.36

6.54

11.6

9.9

7.1

6.8

ug/l

0.10

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

2.72

6.51

1.3

1.9

1.5

mg/l

1.20

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

148

2.26

6.45

1.2

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.06

6.38

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

106

392

1.74

6.36

1.9

1.5

2.9

2.0

ug/l

0.78

232

(3041806) Other cells [#/volume] in Blood by Manual count

733

0.51

6.25

1.8

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

210

2.02

6.24

1.3

1.2

137.7

60.7

u/l

0.64

152

(3020393) Adenovirus Ag [Presence] in Stool

180

2.11

6.22

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

107

402

1.71

6.09

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

178

2.10

6.04

1.5

2.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

166

2.13

5.97

1.1

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.21

5.96

2.9

3.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

246

1.91

5.91

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

106

401

1.70

5.91

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

135

544

1.60

5.90

1.2

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

292

1.83

5.90

2.5

2.7

58.7

67.5

pmol/l

0.35

254

(3041918) Cholesterol [Moles/volume] in Pleural fluid

325

1.78

5.88

1.2

1.7

1.6

mmol/l

0.23

188

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

288

1.83

5.86

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

106

402

1.70

5.86

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.63

5.82

11.5

8.7

—

(3017509) Phencyclidine [Presence] in Urine

252

1.89

5.81

1.8

1.6

—

(3035082) Kappa light chains [Mass/volume] in Urine

3.45

5.81

1.0

1.1

0.0

0.1

g/l

—

(3006969) Lambda light chains [Mass/volume] in Urine

3.55

5.78

1.0

1.1

0.0

0.1

g/l

—

(3051101) Glucose [Moles/volume] in Cord blood

491

0.43

5.68

5.8

5.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

100

2.44

5.63

1.2

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.59

5.61

1.2

1.4

0.9

0.6

u/field

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

678

3582

1.22

5.57

4.2

2.9

32.7

30.2

u/ml

0.27

655

3446

(3013293) Extractable nuclear Ab [Presence] in Serum

346

1.73

5.53

1.6

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

109

2.36

5.51

1.1

29.7

20.5

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

109

2.36

5.51

1.1

45.7

21.2

u/ml

0.77

(3038177) Helicobacter pylori Ab [Presence] in Serum

748

3997

1.21

5.48

1.3

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

177

2.03

5.44

1.2

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

334

1.73

5.40

1.1

1.2

2.0

4.1

u/ml

0.33

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.09

5.40

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

602

0.50

5.35

2.7

3.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

127

2.23

5.35

9.3

3.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

601

0.50

5.33

5.4

6.9

—

(3020650) Glucose [Presence] in Urine

146

619

1.52

5.18

1.5

1.3

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.51

5.03

1.1

0.5

0.6

umol/24h

0.03

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.36

5.00

1.5

1.8

0.9

0.7

umol/l

0.83

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

251

1187

1.36

4.97

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

203

1.90

4.87

1.4

70.3

71.7

0.12

168

(3021661) Pineapple IgE Ab [Units/volume] in Serum

4.29

4.87

1.1

1.0

0.1

0.2

u/ml

—

(3036005) Urine sediment comments by Light microscopy Narrative

5.44

4.86

1.0

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

231

1.84

4.84

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1272

9288

0.88

4.80

1.9

1.8

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

151

2.04

4.77

1.1

1.0

12.1

12.3

iu/ml

0.01

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

416

2123

1.26

4.76

1.2

1.3

11.9

mmol/l

0.04

210

471

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.77

4.74

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

392

0.43

4.71

1.4

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

829

4539

1.18

4.69

1.7

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

188

1.92

4.67

1.2

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.53

4.66

1.0

—

(3019174) dRVVT (LA screen)

203

1.87

4.58

1.3

1.2

—

(3024316) Viscosity of Plasma

2.30

4.50

1.7

1.9

1.5

1.7

mpas

0.96

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.40

4.49

1.0

0.1

0.0

u/ml

0.38

(3032743) Legionella sp IgG Ab [Presence] in Serum

147

2.01

4.41

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

150

1369

0.70

4.33

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

634

0.57

4.32

2.6

2.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

267

1.71

4.17

1.1

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

267

1.71

4.17

1.3

1.2

2.1

1.4

mmol/l

0.35

163

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.55

4.11

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.45

4.09

1.4

1.5

414.0

539.5

nmol/l

0.73

(3039744) RNA polymerase III Ab [Units/volume] in Serum

193

1.83

4.07

1.0

4.7

4.9

u/ml

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.32

4.05

3.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

339

1.61

4.02

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

504

2681

1.21

4.01

1.9

2.1

9.8

7.1

umol/l

1.27

372

1950

(3004446) Plasmodium sp identified in Blood by Light microscopy

228

1.75

3.95

2.4

2.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

145

1.95

3.92

1.2

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.27

3.89

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

141

1.96

3.89

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

155

1.91

3.86

1.2

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.21

3.81

1.0

0.2

0.1

u/ml

0.48

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

309

1.62

3.81

1.2

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

3.04

3.78

1.0

1.4

14.3

41.4

e6/l

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.35

3.77

1.7

1.3

1.0

1.2

u/field

0.53

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.46

3.77

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

144

654

1.42

3.74

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

214

1.74

3.68

1.3

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

181

1.81

3.68

1.1

21.2

19.4

u/l

0.26

116

(3035933) Granulocytes/100 leukocytes in Blood

131

587

1.44

3.67

1.4

2.0

—

(3049242) von Willebrand panel - Platelet poor plasma

2.45

3.67

1.3

1.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.40

3.67

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

308

1.61

3.64

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

721

5359

0.86

3.63

5.0

2.9

23.7

26.8

mg/l

1.64

433

3448

(3041672) Baker's yeast Ab [Presence] in Serum

2.19

3.62

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

286

1448

1.27

3.62

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

2.82

3.57

1.0

1.1

85.6

38.7

mu/l

0.60

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.03

3.55

1.0

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.14

3.55

1.1

256.2

383.8

u/l

0.74

(3046861) Legionella sp Ag [Presence] in Urine

106

2.06

3.54

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

9.00

3.47

2.3

1.8

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

125

1.95

3.45

1.0

0.2

0.4

u/ml

0.57

114

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.08

3.41

1.6

1.5

0.4

0.1

u/l

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.66

3.40

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

143

1258

0.73

3.40

2.1

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

249

1.65

3.40

1.3

1.4

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.50

3.36

4.3

6.6

1.5

1.0

mg/l

0.64

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

635

3508

1.17

3.35

1.1

2.6

3.1

u/ml

0.49

228

1855

(3002853) Influenza virus B Ab [Titer] in Serum

6.43

3.30

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

6.43

3.30

3.1

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

174

1.77

3.27

1.0

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.52

3.26

1.1

1.2

—

(36303858) Crystals [Presence] in Urine

3.72

3.26

1.2

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

380

2012

1.22

3.26

3.3

3.4

48.1

40.7

u/ml

0.25

371

1992

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.40

3.25

1.1

—

mmol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

110

1.99

3.25

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

133

1.89

3.22

1.2

1.1

13.4

14.5

nmol/l

—

(40758292) HTLV I+II Ab panel - Serum

330

1.54

3.17

1.5

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

117

1.92

3.07

1.0

—

(3018133) Calcium [Moles/volume] in Urine

298

1.55

3.02

1.7

2.6

2.8

mmol/l

0.33

267

(3007919) Fasciola sp Ab [Titer] in Serum

2.71

2.99

1.1

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

6.43

2.94

1.1

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

3.21

2.94

1.0

—

(3000285) Sodium [Moles/volume] in Blood

280

1.56

2.93

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

832

4735

1.13

2.93

1.2

1.1

1.5

1.4

u/ml

0.09

359

1806

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.98

2.85

1.0

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.54

2.84

1.0

0.2

0.7

u/ml

0.77

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

360

1.48

2.84

7.1

7.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

144

1.79

2.83

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1935

11518

1.08

2.82

1.9

1.8

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

2.69

0.0

8.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.26

2.64

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.61

2.64

2.5

1.4

2.6

mu/l

0.86

(3003888) Timothy IgE Ab [Units/volume] in Serum

749

4268

1.13

2.63

1.1

3.5

4.8

u/ml

2.24

383

2134

(40768800) Prostate Pathology biopsy report

794

4547

1.12

2.58

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

275

1.52

2.53

2.5

2.3

0.4

0.6

u/field

0.63

275

(3042301) Urate [Moles/volume] in Synovial fluid

2.65

2.53

1.0

375.7

326.9

umol/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

287

1521

1.21

2.53

1.0

270.7

331.8

ng/l

3.65

213

1076

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

226

1171

1.24

2.48

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

288

1532

1.21

2.46

1.0

802.2

711.8

ng/l

2.72

205

1046

(40765089) Chromosome analysis panel - Blood by G-banded

689

0.70

2.43

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

288

1534

1.21

2.43

1.0

36.1

43.3

ng/l

3.00

207

1067

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2421

14621

1.07

2.42

2.1

1.9

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

407

2237

1.17

2.41

3.8

4.9

191.0

93.0

u/ml

0.95

102

720

(3011335) Digoxin [Mass/volume] in Serum or Plasma

152

1.69

2.41

2.5

2.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.88

2.35

5.7

2.2

26.5

20.1

0.66

(46235168) Fasting glucose [Moles/volume] in Blood

325

0.57

2.33

1.2

1.5

7.3

7.1

mmol/l

0.10

116

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

115

979

0.75

2.32

2.1

2.5

125.5

155.3

nmol/l

2.52

853

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

246

1.52

2.27

1.1

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

242

1883

0.83

2.26

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

128

628

1.31

2.22

1.1

2.3

1.6

u/ml

0.23

309

(3045177) Copper [Moles/volume] in Urine

2.66

2.21

1.1

0.3

0.7

umol/l

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

4.09

2.18

1.1

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

668

4801

0.89

2.17

1.5

1.6

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.92

2.14

1.1

1.2

—

(3034614) HLA Ag [Interpretation]

2.19

2.13

1.4

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

199

1.55

2.10

1.6

—

(3018291) Platelet Ab [Presence] in Serum

2.57

2.08

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

110

1.75

2.08

1.6

1.4

23.9

22.8

mmol/l

0.39

(3008401) Mugwort IgE Ab [Units/volume] in Serum

705

4069

1.12

2.08

1.1

0.8

1.1

u/ml

1.00

309

1637

(3013945) Hepatitis B virus e Ab [Presence] in Serum

140

1.65

2.04

1.4

—

(40759632) Porphyrins [Mass/mass] in Stool

2.79

2.00

1.1

1.0

—

(3027874) Urate [Moles/volume] in Urine

1.95

1.91

1.1

1.0

1.6

10.3

mmol/l

0.52

(3019768) Coxiella burnetii Ab [Presence] in Serum

133

1.64

1.90

1.4

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

125

1.65

1.81

1.1

1.3

2.6

1.5

0.45

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.20

1.79

1.3

1.5

244.3

139.3

nmol/l

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.26

1.77

1.8

1.4

2.0

2.1

mmol/24h

0.05

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.06

1.77

1.3

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.57

1.75

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.57

1.75

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.57

1.75

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.57

1.75

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.57

1.75

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.57

1.75

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.10

1.74

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

365

2050

1.15

1.73

1.4

1.3

134.5

120.6

pmol/l

0.07

166

595

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

290

0.62

1.73

6.3

7.7

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

112

1.66

1.72

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

3.51

1.71

2.8

1.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

174

1.51

1.68

1.2

1.4

5.7

15.1

pmol/l

4.68

142

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

3.00

1.67

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.84

1.65

1.1

1.2

1568.9

2958.9

ng/l

—

(3009677) Dengue virus Ab [Presence] in Serum

1.74

1.61

1.1

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

140

1.56

1.60

2.6

3.7

51.7

40.3

g/mol

0.29

126

(3007147) Virus identified in Stool by Electron microscopy

3.21

1.58

1.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.01

1.58

1.1

1.0

0.0

0.3

u/ml

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.81

1.56

1.0

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.72

1.55

1.5

1.2

0.1

g/l

0.08

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.63

1.53

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

132

1.56

1.51

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

1.80

1.48

1.0

—

(40760410) HLA-B [Type] by High resolution

1.80

1.48

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.80

1.48

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

310

1.35

1.47

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

257

1.38

1.42

1.7

1.5

11.9

5.6

nmol/l

0.36

246

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

150

1.50

1.41

1.2

1.5

6.7

13.5

3.02

104

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

245

1362

1.16

1.41

1.3

5.8

5.7

mmol/l

0.76

226

1286

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.96

1.39

1.1

1.6

2.7

1.46

(3010726) Horse dander IgE Ab [Units/volume] in Serum

665

3923

1.09

1.38

1.1

2.1

u/ml

2.88

168

909

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.75

1.37

1.0

1.1

28.5

33.6

umol/l

—

(4038314)

178

0.58

1.37

1.3

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

110

1.58

1.36

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.62

1.35

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.23

1.35

1.4

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.85

1.30

1.1

1.2

—

(3041184) Isoniazid [Presence] in Urine

2.14

1.29

2.0

2.9

—

(3011544) Albumin [Mass/volume] in Pleural fluid

164

1.45

1.29

1.1

15.6

16.8

g/l

0.39

151

(3014178) Parietal cell Ab [Units/volume] in Serum

2.57

1.27

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

224

1251

1.15

1.24

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

118

1.53

1.24

1.0

0.5

0.4

u/ml

0.06

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

337

1.30

1.23

1.1

0.4

1.1

u/ml

0.71

229

(3007700) Barley IgE Ab [Units/volume] in Serum

103

1.56

1.22

1.0

0.1

0.5

u/ml

0.96

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.24

1.22

1.1

1.0

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.67

1.21

1.0

0.1

0.3

u/ml

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

244

1783

0.88

1.20

1.3

1.4

1.5

g/l

0.20

108

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

333

1.29

1.19

1.1

1.3

37.5

51.9

1.72

155

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.84

1.19

1.0

661.4

246.7

u/l

0.37

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

189

1.39

1.18

1.0

0.0

1.4

u/ml

0.66

139

(3034092) Cytoplasmic Ig cells/100 cells in Blood

345

0.73

1.17

14.6

7.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

158

1.42

1.14

2.1

2.9

16.2

41.0

pmol/l

0.66

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

137

1.45

1.13

1.3

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

348

2016

1.11

1.1

—

90.0

titre

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

138

1.44

1.09

1.0

0.2

1.5

u/ml

0.77

101

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.82

1.09

1.0

—

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.55

1.08

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.07

1.07

1.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

194

1.36

1.04

1.0

0.0

0.5

u/ml

1.33

134

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.59

1.02

1.6

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

173

1.37

1.02

1.2

1.5

50.0

38.1

1.04

116

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.05

1.00

3.0

2.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

136

1.42

0.98

1.0

—

(40763590) HLA-DQ beta [Type]

1.61

0.97

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.96

0.95

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.27

0.94

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.75

0.92

1.3

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

535

3201

1.08

0.89

1.1

1.0

3.3

4.2

u/ml

0.49

236

1289

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

314

1.25

0.89

3.0

2.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.47

0.89

1.2

1.3

—

(3013862) HLA-DP [Type]

1.56

0.88

1.0

—

(4133840)

124

686

1.16

0.86

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3668

24177

0.97

0.85

1.4

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.52

0.84

1.2

1.1

279.4

229.7

nmol/l

0.57

(3006567) Chloride [Moles/time] in 24 hour Urine

1.72

0.81

1.2

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

204

1.29

0.80

1.0

0.2

0.4

u/ml

0.21

113

(3038515) Glucose [Moles/volume] in Venous blood

721

4903

0.94

0.80

4.3

2.9

7.5

7.6

mmol/l

0.30

706

4827

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.30

0.78

1.4

1.1

43.0

27.0

nmol/24h

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

2.30

0.78

4.6

2.9

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.59

0.75

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.14

0.75

1.0

1.3

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.14

0.75

1.2

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

282

1.23

0.73

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

134

1.34

0.72

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

112

1.38

0.72

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.69

0.70

1.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

186

1.28

0.69

1.0

0.3

0.6

u/ml

0.68

106

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

131

0.69

0.65

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.65

0.65

1.0

1.1

85.7

101.9

nmol/24h

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

201

1.25

0.62

1.0

0.1

u/ml

0.11

111

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

252

1495

1.08

0.60

5.5

6.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

162

1.27

0.59

5.1

4.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.68

0.57

2.7

2.9

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

229

1.21

0.53

1.0

0.2

u/ml

0.02

133

(3014599) Egg white IgE Ab [Units/volume] in Serum

214

1485

0.93

0.51

1.0

0.6

2.5

u/ml

1.63

308

(3001218) Citrate [Mass/time] in 24 hour Urine

1.61

0.50

1.6

1.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.46

0.50

5.3

5.7

0.3

0.2

mmol/l

0.71

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.46

0.50

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

116

0.72

0.50

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

109

1.30

0.49

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.55

0.49

1.1

1602.9

2327.2

titre

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

557

3421

1.05

0.48

1.1

2.5

4.2

u/ml

2.58

244

1284

(3002079) Sodium [Moles/time] in 24 hour Urine

1.45

0.46

1.1

1.0

124.8

142.6

mmol/24h

—

(3001729) Color of Synovial fluid

175

1.21

0.44

1.3

1.5

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.69

0.44

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

142

0.77

0.44

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.42

0.0

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1284

8473

0.97

0.42

1.4

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

121

711

1.09

0.41

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

164

978

1.08

0.40

2.1

1.9

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.46

0.40

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.35

0.38

1.6

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

153

1057

0.93

0.37

1.6

1.8

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.63

0.36

1.0

—

10986.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.33

0.35

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

163

1.18

0.34

1.1

1.0

0.1

0.2

u/ml

0.99

(3025130) Human papilloma virus identified in Specimen

566

3517

1.03

0.33

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

285

1.13

0.32

1.2

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

119

713

1.07

0.29

1.1

1.0

4.6

11.3

u/ml

1.69

102

(3008037) Lactate [Moles/volume] in Venous blood

818

5130

1.03

0.28

4.0

2.8

1.6

mmol/l

0.13

799

5042

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.76

0.28

1.8

2.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.25

0.28

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.80

0.27

3.9

3.6

—

0.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

164

1113

0.95

0.27

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

222

1492

0.96

0.25

1.1

1.0

1.1

1.8

u/ml

0.37

360

(3044336) Cobalt [Moles/volume] in Urine

1.29

0.25

2.8

2.5

35.4

27.8

nmol/l

0.13

(3036312) Salmon IgE Ab [Units/volume] in Serum

146

1.14

0.22

1.0

0.0

1.1

u/ml

1.65

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.22

0.0

1.3

—

2.2

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

146.4

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.19

0.21

1.0

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.19

0.21

1.0

1.3

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

147

1.14

0.21

1.4

1.6

0.6

0.06

113

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.21

0.20

1.0

1.1

—

(40768793) Breast Pathology biopsy report

823

5382

0.98

0.18

1.3

—

(3003577) Lead [Moles/volume] in Blood

204

1.10

0.18

1.5

1.4

0.3

0.2

umol/l

0.28

(3013762) Body weight Measured

113

1.14

0.16

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.79

0.16

2.0

2.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

135

835

1.04

0.15

1.1

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

128

1.10

0.12

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

439

2774

1.02

0.12

1.1

1.0

0.3

0.6

u/ml

0.93

112

566

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

287

0.94

0.11

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.15

0.11

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

136

1.09

0.10

1.0

0.1

0.3

u/ml

0.80

(3015076) Soybean IgE Ab [Units/volume] in Serum

202

1325

0.98

0.09

1.0

0.3

0.8

u/ml

0.64

168

(3040794) Aluminum [Moles/volume] in Urine

1.07

0.09

1.2

—

(3022475) Manganese [Moles/volume] in Blood

146

0.92

0.08

1.4

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

436

2771

1.01

0.07

3.0

2.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

151

0.94

0.07

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

443

1.03

0.06

1.5

1.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

152

962

1.02

0.05

1.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

487

0.98

0.05

3.6

2.6

106.2

99.1

ng/l

0.07

204

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

134

1.06

0.04

1.0

0.0

1.1

u/ml

0.82

(3001556) Androgen free Index in Serum or Plasma

218

1.03

0.03

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

536

3460

1.00

0.03

1.2

1.3

7.4

7.2

mmol/l

0.77

407

2461

(44806420)

631

1.01

0.01

2.0

2.4

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

120

0.96

0.01

1.1

0.3

5.0

u/ml

1.08

101

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1486

9544

1.00

0.00

1.7

1.6

4.9

3.1

mg/l

4.10

1213

6477

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.95

0.00

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.00

0.00

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.96

0.00

1.0

—

(40758358) Immune stain study

100

0.96

0.00

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

136

0.99

0.00

1.1

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.01

0.00

1.0

1.1

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_TRAMADOL – Tramadol

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tramadol

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Tramadol (RX_TRAMADOL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints